fluconazole has been researched along with Moniliasis, Oral in 431 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This multicenter, randomized, evaluator-blinded study of subjects with HIV infection and oropharyngeal candidiasis compared efficacy of posaconazole with that of fluconazole." | 9.12 | A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. ( Gogate, J; Greaves, W; Isaacs, R; Nieto, L; Northland, R; Sanne, I; Skiest, DJ; Vazquez, JA, 2006) |
| "We evaluated the efficacy and safety of oral posaconazole for human immunodeficiency virus (HIV)-infected subjects with oropharyngeal candidiasis (OPC) and/or esophageal candidiasis (EC) who were clinically refractory to treatment with oral fluconazole or itraconazole." | 9.12 | Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. ( Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D, 2007) |
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 9.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| "Fluconazole 50 mg daily for 14-28 days was effective in the treatment of patients with AIDS and AIDS-related complex with severe oropharyngeal and oesophageal candidiasis." | 9.06 | Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. ( Dunbar, EM; Ellis, ME; Leen, CL; Mandal, BK, 1990) |
| "A double-blind trial was carried out to study the effect of oral administration of fluconazole in the treatment of Candida-associated denture stomatitis." | 9.06 | Fluconazole in the treatment of Candida-associated denture stomatitis. ( Budtz-Jørgensen, E; Holmstrup, P; Krogh, P, 1988) |
| " Fluconazole (Diflucan((R)), Pfizer) is a triazole that has established an exceptional therapeutic record for candida infections including oropharyngeal and esophageal candidiasis, vulvovaginal candidiasis, candidemia and disseminated candidiasis." | 8.82 | Fluconazole for the treatment of candidiasis: 15 years experience. ( Cha, R; Sobel, JD, 2004) |
| "Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis." | 8.78 | Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993) |
| "We report on the correlation of the outcomes for two cohorts of patients who had been treated for candidemia (126 episodes) or oropharyngeal candidiasis (110 episodes) with various doses of fluconazole and the MIC of fluconazole obtained by using the EUCAST standard for fermentative yeasts." | 7.74 | Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia. ( Almirante, B; Cuenca-Estrella, M; Donnelly, JP; Laguna, F; Mouton, JW; Pahissa, A; Rodríguez-Pardo, D; Rodríguez-Tudela, JL, 2007) |
| " We studied the activity of PLD-118 in escalating dosages against experimental oropharyngeal and esophageal candidiasis (OPEC) caused by fluconazole (FLC)-resistant Candida albicans in immunocompromised rabbits." | 7.72 | Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans. ( Bacher, J; Groll, AH; Kelaher, AM; Mickiene, D; Petraitiene, R; Petraitis, V; Sarafandi, AA; Sein, T; Walsh, TJ, 2004) |
| " We studied the antifungal efficacy, the concentrations in saliva and tissue, and the safety of VER-002 at escalating dosages against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant Candida albicans in immunocompromised rabbits." | 7.71 | Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. ( Bacher, J; Francesconi, A; Groll, AH; Lyman, CA; Petraitiene, R; Petraitis, V; Piscitelli, SC; Schaufele, RL; Sein, T; Walsh, TJ, 2001) |
| "Due to an increasing number of leukemic patients with invasive gingival aspergillosis during neutropenia (neutrophils <500 cells/microl for >10 days), we evaluated the efficacy of oral itraconazole prophylaxis for preventing this invasive infection at our hospital." | 7.71 | Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia. ( Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T, 2002) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 7.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| "Disseminated cryptococcosis developed in an HIV antibody positive patient who was taking fluconazole for oral candidiasis." | 7.68 | Cavitating pulmonary cryptococcosis developing in an HIV antibody patient despite prior treatment with fluconazole. ( Bell, D; Coker, RJ; Murphy, SM; Peters, BS, 1992) |
| "The efficacy and safety of fluconazole, a new triazole antifungal agent, was evaluated in 24 patients with neutropenia due to cytotoxic anticancer chemotherapy with polyfactorial immunodepression." | 7.68 | Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients. ( Blahova, M; Fuchsberger, P; Hornikova, M; Koza, I; Krcméry, V; Mardiak, J; Migom, C; Savko, V; Spanik, S; Sufliarsky, J, 1991) |
| "Oral candidiasis is a frequent opportunistic infection in AIDS patients." | 6.67 | [Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)]. ( Coll-Seck, AM; Diop, BM; Faye, MA; Ndiaye, I; Sow, PS, 1993) |
| "Fluconazole is a bis-triazole antifungal agent with a long serum half-life." | 6.67 | Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs. ( Hales, M; Kernoff, PB; Lee, CA; Lim, SG; O'Doherty, M; Winter, M, 1991) |
| "Fluconazole is a new triazole antifungal agent with good activity against Candida and cryptococcal meningitis." | 6.38 | Fluconazole: a new option in the treatment of Candida mucositis and esophageal candidiasis. ( Garber, GE, 1992) |
| " The concentrations of fluconazole in plasma were maintained above the MICs for FS isolates throughout the dosing interval." | 5.31 | Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. ( Bacher, JD; Gonzalez, CE; Katsov, V; Kligys, K; Lyman, CA; Peter, J; Piscitelli, S; Shetti, D; Torres, R; Walsh, TJ, 2000) |
| "Treatment with fluconazole was ineffective, but amphotericin B was curative." | 5.29 | Candida albicans osteomyelitis of the zygomatic bone. A distinctive case with a possible peculiar mechanism of infection and therapeutic failure with fluconazole. ( Arranz-Caso, JA; García-Altozano, J; Gomez-Herruz, P; Lopez-Pizarro, VM; Martinez-Martinez, J, 1996) |
| "Treatment with fluconazole, 200 mg/day, was introduced." | 5.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| "This multicenter, randomized, evaluator-blinded study of subjects with HIV infection and oropharyngeal candidiasis compared efficacy of posaconazole with that of fluconazole." | 5.12 | A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. ( Gogate, J; Greaves, W; Isaacs, R; Nieto, L; Northland, R; Sanne, I; Skiest, DJ; Vazquez, JA, 2006) |
| "We evaluated the efficacy and safety of oral posaconazole for human immunodeficiency virus (HIV)-infected subjects with oropharyngeal candidiasis (OPC) and/or esophageal candidiasis (EC) who were clinically refractory to treatment with oral fluconazole or itraconazole." | 5.12 | Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. ( Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D, 2007) |
| "The efficacy and safety of caspofungin were compared with fluconazole in adult patients with Candida esophagitis in a double-blind randomized trial." | 5.10 | A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. ( Arathoon, EG; DiNubile, MJ; Gotuzzo, E; Kartsonis, NA; Lupinacci, RJ; Noriega, LM; Sable, CA; Smietana, JM; Villanueva, A, 2002) |
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 5.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| "Fluconazole 50 mg daily for 14-28 days was effective in the treatment of patients with AIDS and AIDS-related complex with severe oropharyngeal and oesophageal candidiasis." | 5.06 | Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. ( Dunbar, EM; Ellis, ME; Leen, CL; Mandal, BK, 1990) |
| "In a randomised, double-blind study the efficacy and toxicity of oral fluconazole 50 mg daily and ketoconazole 200 mg daily were compared for the treatment of oropharyngeal candidiasis in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC)." | 5.06 | Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. ( Clumeck, N; De Wit, S; Goossens, H; Weerts, D, 1989) |
| "A double-blind trial was carried out to study the effect of oral administration of fluconazole in the treatment of Candida-associated denture stomatitis." | 5.06 | Fluconazole in the treatment of Candida-associated denture stomatitis. ( Budtz-Jørgensen, E; Holmstrup, P; Krogh, P, 1988) |
| " Fluconazole (Diflucan((R)), Pfizer) is a triazole that has established an exceptional therapeutic record for candida infections including oropharyngeal and esophageal candidiasis, vulvovaginal candidiasis, candidemia and disseminated candidiasis." | 4.82 | Fluconazole for the treatment of candidiasis: 15 years experience. ( Cha, R; Sobel, JD, 2004) |
| "A systematic review of randomized clinical trials published between 1966 and April 2000 was undertaken to determine the strength of evidence for the effectiveness of antifungal drugs (nystatin, clotrimazole, amphotericin B, fluconazole, ketoconazole, and itraconazole) to prevent and treat oral candidiasis in human immunodeficiency virus-positive patients." | 4.81 | A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. ( Bonito, AJ; Patton, LL; Shugars, DA, 2001) |
| "The clinical use of fluconazole in dosages > or = 800 mg/day has been reported in about 900 patients against candidemia, oropharyngeal candidiasis and cryptococcal meningitis in HIV-infected patients as well as for initial therapy of endemic mycoses." | 4.79 | [High-dose therapy with fluconazole > or = 800 mg/day. Review]. ( Penk, A; Pittrow, L, 1997) |
| "Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis." | 4.78 | Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993) |
| "We report on the correlation of the outcomes for two cohorts of patients who had been treated for candidemia (126 episodes) or oropharyngeal candidiasis (110 episodes) with various doses of fluconazole and the MIC of fluconazole obtained by using the EUCAST standard for fermentative yeasts." | 3.74 | Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia. ( Almirante, B; Cuenca-Estrella, M; Donnelly, JP; Laguna, F; Mouton, JW; Pahissa, A; Rodríguez-Pardo, D; Rodríguez-Tudela, JL, 2007) |
| " We studied the activity of PLD-118 in escalating dosages against experimental oropharyngeal and esophageal candidiasis (OPEC) caused by fluconazole (FLC)-resistant Candida albicans in immunocompromised rabbits." | 3.72 | Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans. ( Bacher, J; Groll, AH; Kelaher, AM; Mickiene, D; Petraitiene, R; Petraitis, V; Sarafandi, AA; Sein, T; Walsh, TJ, 2004) |
| " We studied the antifungal efficacy, the concentrations in saliva and tissue, and the safety of VER-002 at escalating dosages against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant Candida albicans in immunocompromised rabbits." | 3.71 | Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. ( Bacher, J; Francesconi, A; Groll, AH; Lyman, CA; Petraitiene, R; Petraitis, V; Piscitelli, SC; Schaufele, RL; Sein, T; Walsh, TJ, 2001) |
| "Due to an increasing number of leukemic patients with invasive gingival aspergillosis during neutropenia (neutrophils <500 cells/microl for >10 days), we evaluated the efficacy of oral itraconazole prophylaxis for preventing this invasive infection at our hospital." | 3.71 | Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia. ( Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T, 2002) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 3.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| "Disseminated cryptococcosis developed in an HIV antibody positive patient who was taking fluconazole for oral candidiasis." | 3.68 | Cavitating pulmonary cryptococcosis developing in an HIV antibody patient despite prior treatment with fluconazole. ( Bell, D; Coker, RJ; Murphy, SM; Peters, BS, 1992) |
| "The efficacy and safety of fluconazole, a new triazole antifungal agent, was evaluated in 24 patients with neutropenia due to cytotoxic anticancer chemotherapy with polyfactorial immunodepression." | 3.68 | Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients. ( Blahova, M; Fuchsberger, P; Hornikova, M; Koza, I; Krcméry, V; Mardiak, J; Migom, C; Savko, V; Spanik, S; Sufliarsky, J, 1991) |
| "We describe a patient with the acquired immunodeficiency syndrome who had persistent oral esophageal pseudomembranous candidiasis clinically refractory to nystatin, clotrimazole, and ketoconazole." | 3.68 | Treatment of refractory oral candidiasis with fluconazole. A case report. ( Chafey, S; Franker, C; Hardy, WD; Lucatorto, FM, 1991) |
| "PDT was effective in the treatment of oral candidiasis; PDT was more effective than nystatin for the treatment of denture stomatitis in the palate, while there was no significant difference between the two for the denture site; The efficacy of PDT for oral candidiasis was similar to that of fluconazole; PDT was less effective than miconazole for oral candidiasis; Compared with nystatin alone, the combination of PDT and nystatin is more effective in treating oral candidiasis with less risk of recurrence." | 3.01 | Efficacy of photodynamic therapy in the treatment of oral candidiasis: a systematic review and meta-analysis. ( Hu, Q; Li, T; Liu, N; Liu, Q; Peng, Y; Yang, J, 2023) |
| " The challenge today is the development of alternative anti-oral candidiasis drugs with increased efficacy, bioavailability and better outcome which can combat azole resistance." | 2.82 | Efficacy of Flavonoids in Combating Fluconazole Resistant Oral Candidiasis. ( Awasthi, H; Fatima, Z; Naqvi, S; Srivastava, D; Yadav, A, 2022) |
| "Fluconazole has a broad spectrum antifungal activity including a wide variety of candida species." | 2.76 | A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis. ( Charyulu, NR; Nairy, HM; Prabhakara, P; Shetty, VA, 2011) |
| "The meta-analysis showed that, in the treatment of oral candidiasis in reducing the mycological cure rate, itraconazole capsules, itraconazole oral solution, miconazole buccal tablets, miconazole oral gel, clotrimazole, fluconazole, ketoconazole, nystatin, and amphotericin B were better than a placebo." | 2.72 | Efficacy of antifungal drugs in the treatment of oral candidiasis: A Bayesian network meta-analysis. ( Ding, Z; Fang, J; Huang, B, 2021) |
| "Fluconazole was ranked the safest among other antifungal agents (SUCRA = 0." | 2.72 | Antifungal agents in preventing oral candidiasis in clinical oncology: A network meta-analysis. ( Gopinath, D; Kunnath Menon, R; Mooi Ching, S; Se Wong, P; Shen Loo, Y; Veettil, SK; Yee Wong, T, 2021) |
| "Patients undergoing radiotherapy for head and neck cancer are at increased risk of developing oral candidiasis." | 2.71 | Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers. ( Aktas, E; Koc, M, 2003) |
| "Thirty-seven patients with head-and-neck cancer received EBRT in 2." | 2.71 | Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer. ( Coco, BJ; Dahiya, MC; Dahiya, RS; Eng, TY; Fothergill, AW; Kirkpatrick, WR; Patterson, TF; Redding, SW; Rinaldi, MG; Sadkowski, LC; Thomas, CR; Waite, A, 2003) |
| "Fluconazole is a systemic antifungal medication that demonstrated clinical advantages in rinsing before swallowing." | 2.70 | Fluconazole mouthrinses for oral candidiasis in postirradiation, transplant, and other patients. ( Caldwell, J; Epstein, JB; Gorsky, M, 2002) |
| "Fluconazole was compared with nystatin for the treatment of oral candidiasis in infants." | 2.70 | Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. ( Arnold, J; Ascher, D; Goins, RA; Moorefield, E; Waecker, N, 2002) |
| "Treatment with fluconazole, but not nystatin, reduced the production of phospholipase from C albicans oral isolates in patients with diabetes mellitus." | 2.70 | The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus. ( Bell, PM; Coulter, WA; Fulton, CR; Hayes, JR; Lamey, PJ; Willis, AM, 2001) |
| "Fluconazole kinetics were best described by a one-compartment model with first-order oral absorp tion from the gastrointestinal tract." | 2.70 | Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients. ( Bille, J; Biollaz, J; Buclin, T; Csajka, C; Décosterd, LA; Fattinger, K; Pagani, JL, 2001) |
| " The incidence of adverse events was 39% for fluconazole and 44% for amphotericin B." | 2.70 | A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis. ( Domenge, C; Lefebvre, JL, 2002) |
| "In patients with frequent recurrences, continuous suppressive therapy significantly reduced relapses and colonization." | 2.69 | A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance. ( Dib, OP; Fothergill, AW; Hilsenbeck, SG; Kirkpatrick, WR; McAtee, RK; Patterson, TF; Redding, SW; Revankar, SG; Rinaldi, MG, 1998) |
| "Fungal infections are a major problem in patients with hematologic malignancy." | 2.68 | Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias. ( Schaffner, A; Schaffner, M, 1995) |
| "Fluconazole (FCZ) has been extensively used as a primary therapy for oropharyngeal candidosis in AIDS patients." | 2.68 | Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole. ( Dromer, F; Dupont, B; Garcia-Hermoso, D; Improvisi, L; Provost, F, 1995) |
| "8 micrograms/ml 4 h after dosage, administration of the suspension resulted in a mean peak concentration of 551." | 2.68 | Pharmacokinetic optimization of the treatment of oral candidiasis with fluconazole: studies with a suspension. ( de los Reyes, C; Laufen, H; Yeates, RA; Zimmermann, T, 1995) |
| " The dosage and therapeutic duration were as follows: Flu 200-400 mg daily for 1-8 weeks in 34 patients with fungal infection and 150 mg as a single dose in 30 patients with fungal vaginitis; Keto 400 mg daily for 1-8 weeks in 30 patients with fungal diseases and for 5 days in 30 patients with fungal vaginitis." | 2.68 | [Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study]. ( Liang, D; Lu, Y; Zhang, H, 1997) |
| "Oral candidiasis is a frequent opportunistic infection in AIDS patients." | 2.67 | [Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)]. ( Coll-Seck, AM; Diop, BM; Faye, MA; Ndiaye, I; Sow, PS, 1993) |
| "Fluconazole has proved to be effective in treating oropharyngeal and esophageal candidiasis in immunocompromised patients." | 2.67 | Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome. ( Akalin, HE; Akova, M; Aslan, S; Hayran, M; Kansu, E; Tekuzman, G; Telatar, H; Uzun, O, 1994) |
| "Fluconazole was given in a mean dosage of 3." | 2.67 | Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole. Multicentre Study Group [corrected]. ( Marchisio, P; Principi, N, 1994) |
| " Twenty-four subjects received oral fluconazole in a dosage of 3 mg/kg/day and 22 subjects received oral ketoconazole in a dosage of 7 mg/kg/day." | 2.67 | Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group. ( Hernández-Sampelayo, T, 1994) |
| "Fluconazole was well tolerated and prevented clinical relapse of oropharyngeal candidiasis in 71% of patients who completed three months of treatment (95% confidence interval [CI], 55-86) and 58% (95% CI, 41-75) who completed six months of treatment." | 2.67 | Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study. ( Harkness, JL; Hoy, JF; Jones, PD; Marriott, DJ; Speed, BR, 1993) |
| "Fluconazole was more effective than clotrimazole in eradicating Candida from the oral flora by the end of therapy (65% versus 48%) (p = 0." | 2.67 | Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group. ( Debruin, M; Greenspan, D; Pons, V, 1993) |
| " In group 2, on 57 of 3316 days (2%), fluconazole in a higher dosage was administered for treatment." | 2.67 | Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. ( Gentschew, G; Helm, EB; Just-Nübling, G; Meissner, K; Odewald, J; Staszewski, S; Stille, W, 1991) |
| "Fluconazole is a bis-triazole antifungal agent with a long serum half-life." | 2.67 | Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs. ( Hales, M; Kernoff, PB; Lee, CA; Lim, SG; O'Doherty, M; Winter, M, 1991) |
| "Fluconazole-treated patients were more likely to remain disease free during follow-up than those treated with clotrimazole (P = 0." | 2.67 | Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. ( Fass, RJ; Koletar, SL; Plouffe, JF; Russell, JA, 1990) |
| "Recent studies on treatment of oral candidiasis were retrieved from PubMed and Cochrane Library." | 2.61 | Therapeutic tools for oral candidiasis: Current and new antifungal drugs. ( Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E, 2019) |
| "In most people, untreated candidiasis persists for months or years unless associated risk factors are treated or eliminated." | 2.45 | Candidiasis (oropharyngeal). ( Pankhurst, CL, 2009) |
| " This formulation has a higher bioavailability and leads to higher local concentrations in the oral cavity which are advantages over the solid capsule formulation." | 2.41 | Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons. ( Beijnen, JH; Bult, A; Koks, CH; Meenhorst, PL, 2002) |
| "Invasive fungal infections have been noted in increasing frequency in immunosuppressed patients and may be due to organisms that are less susceptible or frankly resistant to antifungal agents." | 2.41 | Fungal susceptibility testing: where are we now? ( Patterson, TF, 2002) |
| " A newly recognized phenomenon known as the post-antifungal effect implies that antifungals, even at sub-therapeutic concentrations, may suppress the virulent attributes of yeasts, especially intra-orally where topical drug levels fluctuate dramatically during dosing intervals." | 2.41 | Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis. ( Ellepola, AN; Samaranayake, LP, 2000) |
| "Ketoconazole tablets were used with good success in previous years of the AIDS epidemics." | 2.39 | [Therapy of candidiasis and cryptococcosis in AIDS]. ( Just-Nübling, G, 1994) |
| " The topical agents are available in assorted dosage forms with varying degrees of efficacy and patient acceptability." | 2.39 | Treatment of oropharyngeal candidiasis in HIV-positive patients. ( Greenspan, D, 1994) |
| "Fluconazole is a new triazole antifungal agent with good activity against Candida and cryptococcal meningitis." | 2.38 | Fluconazole: a new option in the treatment of Candida mucositis and esophageal candidiasis. ( Garber, GE, 1992) |
| "Invasive fungal infections are major problems in immunocompromised patients and optimal therapeutical modalities are still far from optimal." | 2.38 | [Current progress in antifungal therapy: the value of fluconazole]. ( Meunier, F, 1990) |
| "Patients with advanced cancer are prone to develop different opportunistic oral infection due to anti-cancer treatment or the malignancies themselves." | 1.91 | Identification and susceptibility testing of oral candidiasis in advanced cancer patients. ( Enersen, M; Fjeld, KG; Gay, CL; Herlofson, BB; Hove, LH; Kristoffersen, AK; Lerdal, A; Monsen, RE; Nordgarden, H; Tollisen, A, 2023) |
| "Oral candidiasis is a common but most harmful oral cavity infection caused by yeast-like fungus, this condition is called Oropharyngeal candidiasis." | 1.91 | Human Oropharyngeal Candidiasis: From Etiology to Current Treatment. ( Ahmad, MH; Bashir, H; Qadir, MI, 2023) |
| "Ethyl caffeate (EC) is a phenylpropanoid compound derived from Elephantopus scaber." | 1.91 | Ethyl caffeate combined with fluconazole exhibits efficacy against azole-resistant oropharyngeal candidiasis via the EFGR/JNK/c-JUN signaling pathway. ( Bao, M; Bu, Q; Li, N; Pan, M; Shao, J; Wang, C; Wang, T; Yang, R; Yang, Y, 2023) |
| "Resistance to azole drugs has been observed in candidiasis due to their long-term use and poor response to treatment." | 1.72 | The evaluation of the overexpression of the ERG-11, MDR-1, CDR-1, and CDR-2 genes in fluconazole-resistant Candida albicans isolated from Ahvazian cancer patients with oral candidiasis. ( Dehghan, P; Fatahinia, M; Maheronnaghsh, M; Teimoori, A, 2022) |
| "Paeonol (PAE) is a traditional medicine with multiple properties." | 1.72 | Paeonol enhances treatment of fluconazole and amphotericin B against oropharyngeal candidiasis through HIF-1α related IL-17 signaling. ( Liu, Y; Niu, X; Pan, M; Shao, J; Wang, Q; Wang, T; Wu, D; Xiao, N; Yan, G, 2022) |
| "Oral candidiasis is an opportunistic disease caused by fungi of the Candida genus." | 1.62 | Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp. ( Araújo, RPC; Deegan, KR; Fonseca, MS; Machado, BAS; Meyer, R; Portela, RW; Sokolonski, AR; Umsza-Guez, MA, 2021) |
| "Amphotericin B and econazole were the most effective antifungals against the isolates." | 1.51 | Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions. ( Dastgheib, L; Ghasemi, N; Jowkar, F; Nouraei, H; Pakshir, K; Zomorodian, K, 2019) |
| "Fluconazole was not effective against preformed mixed- Candida species biofilms while amphotericin B was potent." | 1.48 | Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals. ( Herrera, M; Kadosh, D; Li, X; Mintz, J; Vipulanandan, G; Wickes, BL; Wiederhold, NP, 2018) |
| " albicansin vitro and in vivo even under non-growth inhibitory dosage confirming the virulent contribution of ergosterol biosynthesis pathway." | 1.48 | ERG3 and ERG11 genes are critical for the pathogenesis of Candida albicans during the oral mucosal infection. ( Cheng, L; Feng, M; Hu, Y; Li, M; Liao, M; Peng, X; Ren, B; Tong, T; Zhou, X; Zhou, Y; Zhu, C, 2018) |
| "Oral thrush is a common fungal infection of the mouth experienced by palliative medicine and hospice patients who have advanced cancer." | 1.46 | Single-Dose Fluconazole Therapy for Oral Thrush in Hospice and Palliative Medicine Patients. ( Cheema, B; Cothren, B; Davis, M; Gamier, P; Gopal, S; Lagman, R; LeGrand, S; Parala, A; Rybicki, L; Walsh, D, 2017) |
| "The attitude towards the treatment of oral candidiasis is much better among the least-experienced dentists working in private practice." | 1.42 | Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan. ( Abu-Hammad, OA; Al-Omiri, MK; Al-Shayyab, MH; Dar-Odeh, NS, 2015) |
| "Miltefosine is an alkyl phospholipid with promising antifungal activity." | 1.42 | In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis. ( Chaturvedi, AK; Lopez-Ribot, JL; Rozental, S; Vila, TV, 2015) |
| "Oral candidiasis is an important side effect of topical corticotherapy." | 1.40 | Kinetics of oral colonization by Candida spp. during topical corticotherapy for oral lichen planus. ( Gomes, CC; Gomez, RS; Pereira, Tdos S; Rocha do Nascimento, A; Silva Alves, Jde F; Stoianoff, MA, 2014) |
| " It was effective at concentrations detected in saliva when using standard dosing regimens." | 1.39 | Chlorhexidine is a highly effective topical broad-spectrum agent against Candida spp. ( Moore, C; Rautemaa, R; Salim, N; Satterthwaite, J; Silikas, N, 2013) |
| "Hydroxyurea therapy in sickle cell anemia patients maintains fungal species balance in oral cavity." | 1.39 | Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance. ( Braga, JA; Brighenti, FL; Figueiredo, MS; Koga-Ito, CY; Pereira, DF; Salvia, AC, 2013) |
| "Clinical oral mucositis screenings were performed triweekly." | 1.39 | Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients. ( Freytes, CO; Kirkpatrick, WR; Patterson, TF; Redding, SW; Toro, JJ; Westbrook, SD; Wiederhold, NP, 2013) |
| "Fluconazole resistance was detected in isolates from one patient, and isolates exhibiting a progressive reduction in itraconazole and/or fluconazole susceptibility were identified in a further 3/16 patients, in each case correlating with the upregulation of CDR- and MDR-encoded efflux pumps." | 1.37 | Microbiological screening of Irish patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy reveals persistence of Candida albicans strains, gradual reduction in susceptibility to azoles, and incidences of clinical signs of oral candid ( Coleman, DC; Costigan, C; Fleming, P; Healy, CM; McGovern, E; McManus, BA; Moran, GP; Nunn, J; Sullivan, DJ, 2011) |
| " The dosage forms were designed to release the drug above the minimum inhibitory concentration for prolonged period of time so as to reduce the frequency of administration and to overcome the side effects of systemic treatment." | 1.37 | Preparation of fluconazole buccal tablet and influence of formulation expedients on its properties. ( Mohamed, SP; Muzzammil, S; Pramod, KT, 2011) |
| "Oral candidiasis is the most prevalent complication in HIV-infected and AIDS patients." | 1.36 | In vitro activity of voriconazole against Mexican oral yeast isolates. ( Aguirre, JM; Carrillo-Muñoz, AJ; Eraso, E; Gaitán-Cepeda, LA; Quindós, G; Sánchez Vargas, LO, 2010) |
| "Miconazole (MICON) has long been used for the topical treatment of mucosal candidiasis." | 1.36 | Antifungal activity of miconazole against recent Candida strains. ( Ghannoum, MA; Isham, N, 2010) |
| "albicans (n = 19) isolates from nine APECED patients reported with decreased susceptibility to fluconazole isolated up to 9 years apart were included." | 1.36 | Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. ( Bowyer, P; Rautemaa, R; Richardson, M; Sanglard, D; Saxen, H; Siikala, E, 2010) |
| "Fluconazole is a rare cause of severe cutaneous adverse drug reactions." | 1.35 | Severe cutaneous adverse drug reaction due to fluconazole. ( Brantley, JS; Kelly, BC; Kelso, RL; Lester, LJ; Petitt, MS; Wilkerson, MG, 2008) |
| "Oral cheek mucosal specimens from 52 cancer patients receiving chemotherapy were cultured on CHROMagar Candida plates for Candida identification." | 1.35 | Fluconazole susceptibility and genotypic heterogeneity of oral Candida albicans colonies from the patients with cancer receiving chemotherapy in China. ( Lafleur, MD; Qi, C; Qi, QG; Sun, J, 2009) |
| "Fluconazole (FLC) was used as the control." | 1.35 | In vitro inhibition of oral Candida albicans by chicken egg yolk antibody (IgY). ( Deng, XL; Fan, B; Hu, XY; Li, RY; Liu, LG; Wan, Z; Wang, XZ; Wei, Y, 2008) |
| "Posaconazole was markedly more active than fluconazole and was active against 9/11 fluconazole-resistant Candida albicans, and five Candida glabrata had an MIC of posaconazole of 16 mg/L." | 1.33 | Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections. ( Alonso, R; Carrillo-Muñoz, AJ; del Valle, O; Hernández-Molina, JM; Loebenberg, D; McNicholas, P; Quindós, G; Ruesga, M; Santos, P, 2005) |
| "Oral candidiasis was diagnosed using the criteria described before." | 1.33 | Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. ( Dardoufas, K; Kolitsi, G; Kouloulias, V; Kouvaris, J; Kyprianou, K; Nicolatou-Galitis, O; Papanicolaou, VS; Pissakas, G; Skarleas, C; Sotiropoulou-Lontou, A; Velegraki, A, 2006) |
| "Hoarseness was always present." | 1.33 | Laryngeal thrush. ( Sulica, L, 2005) |
| "Fluconazole resistance was found in five isolates, four exhibited dose-dependent susceptibility and the remainder were fully susceptible to this agent." | 1.33 | Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients. ( Chen, KW; Cheng, HH; Chiou, CS; Hung, CC; Lauderdale, TL; Li, SY; Lo, HJ; Wang, TH; Yang, YL, 2006) |
| "isolated from head and neck cancer patients treated with radiotherapy or chemotherapy to antifungal agents." | 1.33 | [Antifugal susceptibility testing and antifugal traditional Chinese medicines screening of oral Candida isolated from head and neck cancer patients treated with radiotherapy or chemotherapy]. ( Zhang, WD; Zhao, M; Zhou, ZT, 2006) |
| "Oral candidiasis is the most common manifestation, superficial cutaneous infections of the dermis are rarely seen." | 1.32 | Generalized fungal infection in a patient with AIDS appearing as skin papules. ( Altmeyer, P; Brockmeyer, NH; Kreuter, A; Stuecker, M; Teichmann, M; Tietz, HJ, 2003) |
| "Fluconazole MICs were determined by using NCCLS methods." | 1.31 | Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. ( Bachmann, SP; Coco, BJ; Kirkpatrick, WR; López-Ribot, JL; Martinez, M; Patterson, TF, 2002) |
| " The concentrations of fluconazole in plasma were maintained above the MICs for FS isolates throughout the dosing interval." | 1.31 | Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. ( Bacher, JD; Gonzalez, CE; Katsov, V; Kligys, K; Lyman, CA; Peter, J; Piscitelli, S; Shetti, D; Torres, R; Walsh, TJ, 2000) |
| "Treatment with fluconazole at 5 or 10 mg kg(-1) per day were equivalent to each other and efficacious in reducing the fungal burden from all four tissues compared with no treatment or lower doses of fluconazole (P < 0." | 1.31 | Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-gamma. ( Clemons, KV; Stevens, DA, 2000) |
| "Treatment of recurrence or persistence was again most commonly nystatin for both mother and infant, followed by oral nystatin for the infant and oral fluconazole for the mother or oral fluconazole for both." | 1.31 | Thrush in the breastfeeding dyad: results of a survey on diagnosis and treatment. ( Brent, NB, 2001) |
| "Fluconazole treatment was ineffective for patients infected with resistant isolates; however, high doses of ketoconazole or itraconazole were successful for nine (81%) of them." | 1.30 | Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans. ( Díaz-Guerra, TM; Dronda, F; Laguna, F; Martínez-Súarez, JV; Polo, R; Pulido, F; Rodríguez-Tudela, JL; Valencia, E, 1997) |
| "Fluconazole resistance has emerged among Candida albicans isolates and has been associated with the prolonged or repeated use of the drug." | 1.30 | Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates. ( Dromer, F; Dupont, B; Eliaszewicz, M; Feuillie, V; Fournier, S; Improvisi, L; Pialoux, G, 1997) |
| " In order to determine the microsomal enzyme activity, the 6-beta-hydroxycortisol/17-hydroxycorticosteroid ratio and antipyrine pharmacokinetic parameters were determined." | 1.30 | Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients. ( Barthel, B; Brockmeyer, NH; Goos, M; Mertins, L; Tillmann, I, 1997) |
| " glabrata was less susceptible (4-8 mg/l) or resistant (> 8 mg/l) to fluconazole and resistant to itraconazole and ketoconazole High dosed intravenous fluconazole treatment with 400 to 600 mg daily failed in 11 patients with fluconazole resistant C." | 1.30 | [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole]. ( Hofmann, H; Metzger, S, 1997) |
| "Oral candidiasis is one of the earliest and most frequent complications of a failing immune system in HIV-infected individuals." | 1.30 | Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. ( Pfaller, MA; Redding, SW; Rinaldi, MG; Smith, J; White, TC, 1997) |
| "albicans by neutrophils in 10 AIDS patients and 50 control subjects." | 1.30 | Neutrophil phagocytosis in AIDS patients with azole resistant candidiasis. ( Castro, M; Diz Dios, P; Iglesias, I; Ocampo, A; Valcarcel, JP; Vazquez, E, 1997) |
| " Further, these results may have an important bearing on dosage regimens currently employed in treating oral candidosis." | 1.30 | Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents. ( Ellepola, AN; Samaranayake, LP, 1998) |
| "isolated from the oral cavities of AIDS patients." | 1.30 | Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure. ( Burattini, MN; Colombo, AL; Costa, PR; Fischmann, O; Kallás, EG; Milan, EP, 1998) |
| "Rilopirox was found to be able to inhibit growth of all clinical yeast isolates." | 1.30 | In vitro activity of rilopirox against fluconazole-susceptible and fluconazole-resistant Candida isolates from patients with HIV infection. ( Haustein, UF; Nenoff, P; Oswald, U; Pfeil, B; Taneva, E, 1999) |
| " The results of this study demonstrates that the fluconazole suppository formulation is effective, safe and well tolerated." | 1.30 | Efficacy, safety and toleration of fluconazole suppositories in the treatment of oral candidosis. ( Heise, W; Migdal, M; Plettenberg, A; Sarnow, E; Schlote, F; Stoehr, A, 1999) |
| "Fluconazole has proven efficacy in prophylaxis, treatment and suppressive therapy of both systemic and superficial fungal infections, especially in candidosis and cryptococcosis." | 1.30 | Therapeutic experience with fluconazole in the treatment of fungal infections in diabetic patients. ( Penk, A; Pittrow, L, 1999) |
| "Eight cases of severe mucosal candidiasis in patients with AIDS who were taking fluconazole at a dosage of 400-800 mg/d are described." | 1.29 | Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. ( Fisher, A; Flanigan, TP; Newman, SL; Rinaldi, MG; Stein, M; Vigilante, K, 1994) |
| "In contrast, for patients with AIDS and oropharyngeal candidiasis infected with a single DNA subtype of C." | 1.29 | Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. ( Farinacci, G; Fothergill, AW; Pfaller, MA; Redding, SW; Rhine-Chalberg, J; Rinaldi, MG; Smith, J, 1994) |
| "Treatment with fluconazole (100 mg/day) was successful in 86% of the cases." | 1.29 | Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients. ( Baquero, F; Fortún, J; Giner, C; Guerrero, A; Navas, E; Pereira, E; Polanco, AM; Quereda, C; Sánchez-Sousa, A, 1996) |
| "The fluconazole dosages were as follows: 0." | 1.29 | Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model. ( Barchiesi, F; Graybill, JR; Luther, MF; Najvar, LK; Rinaldi, MG; Scalise, G, 1996) |
| "Treatment with fluconazole was ineffective, but amphotericin B was curative." | 1.29 | Candida albicans osteomyelitis of the zygomatic bone. A distinctive case with a possible peculiar mechanism of infection and therapeutic failure with fluconazole. ( Arranz-Caso, JA; García-Altozano, J; Gomez-Herruz, P; Lopez-Pizarro, VM; Martinez-Martinez, J, 1996) |
| "Fluconazole has to be reserved to oral candidiasis after failure of a local treatment or to severe cases." | 1.29 | [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV]. ( Barale, T; Drobacheff, C; Laurent, R; Manteaux, A; Millon, L; Reboux, G, 1996) |
| "Treatment with fluconazole, 200 mg/day, was introduced." | 1.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| "The use of preventive treatment for fungal infections is cautioned due to the possibility of resistance to treatment." | 1.29 | Fungal infection overview. ( , 1995) |
| "esophagitis is common in HIV-infected patients." | 1.28 | Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. ( Aguado, AG; Khamashta, MA; López-Dupla, M; Mora Sanz, P; Pintado García, V; Uriol, PL; Valencia Ortega, E, 1992) |
| "Thirty adults (15 with ARC and 15 with AIDS) with a first episode of thrush candidiasis were given oral fluconazole (Triflucan 50 mg; one capsule daily) for at least three months." | 1.28 | [Treatment and secondary prophylaxis with fluconazole for oropharyngeal candidiasis in HIV-positive patients. A mycological analysis of failures]. ( André, D; Bastide, JM; Janbon, F; Mallié, M; Reynes, J, 1992) |
| "Fluconazole was markedly effective against septicemia due to Candida and oral candidiasis accompanied with lingual ulcer in spite of seriousness of these underlying disease." | 1.28 | [Clinical evaluation of fluconazole in patients with mycotic infection]. ( Adachi, M; Ikeda, H; Kawanishi, M; Matsushima, T; Nakamura, J; Tanabe, J; Tano, Y; Tomizawa, S, 1989) |
| "Fluconazole was well tolerated by all patients and there were no significant changes in haematological or hepatic parameters that could be attributed to the drug." | 1.27 | Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients. ( Drouhet, E; Dupont, B, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (2.78) | 18.7374 |
| 1990's | 213 (49.42) | 18.2507 |
| 2000's | 124 (28.77) | 29.6817 |
| 2010's | 61 (14.15) | 24.3611 |
| 2020's | 21 (4.87) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, FM | 1 |
| Staudigel, A | 1 |
| Salvenmoser, S | 1 |
| Tredup, A | 1 |
| Miltenberger, R | 1 |
| Herrmann, JV | 1 |
| Tsai, HF | 1 |
| Sammons, LR | 1 |
| Zhang, X | 1 |
| Suffis, SD | 1 |
| Su, Q | 1 |
| Myers, TG | 1 |
| Marr, KA | 2 |
| Bennett, JE | 1 |
| Sokolonski, AR | 1 |
| Fonseca, MS | 1 |
| Machado, BAS | 1 |
| Deegan, KR | 1 |
| Araújo, RPC | 1 |
| Umsza-Guez, MA | 1 |
| Meyer, R | 1 |
| Portela, RW | 1 |
| Xiao, Y | 1 |
| Yuan, P | 1 |
| Sun, Y | 1 |
| Xu, Y | 2 |
| Deng, X | 1 |
| Wang, X | 1 |
| Liu, R | 1 |
| Chen, Q | 1 |
| Jiang, L | 2 |
| Maheronnaghsh, M | 1 |
| Teimoori, A | 1 |
| Dehghan, P | 1 |
| Fatahinia, M | 2 |
| Pan, M | 2 |
| Wang, Q | 1 |
| Liu, Y | 1 |
| Xiao, N | 1 |
| Niu, X | 1 |
| Wu, D | 1 |
| Wang, T | 2 |
| Yan, G | 1 |
| Shao, J | 2 |
| Srivastava, D | 1 |
| Yadav, A | 1 |
| Naqvi, S | 1 |
| Awasthi, H | 1 |
| Fatima, Z | 1 |
| Erfaninejad, M | 1 |
| Zarei Mahmoudabadi, A | 1 |
| Maraghi, E | 1 |
| Hashemzadeh, M | 1 |
| Monsen, RE | 1 |
| Kristoffersen, AK | 1 |
| Gay, CL | 1 |
| Herlofson, BB | 1 |
| Fjeld, KG | 1 |
| Hove, LH | 1 |
| Nordgarden, H | 1 |
| Tollisen, A | 1 |
| Lerdal, A | 1 |
| Enersen, M | 1 |
| Hatami, F | 1 |
| Manifar, S | 1 |
| Asghari-Paskiabi, F | 1 |
| Bagheri Amiri, F | 1 |
| Nojoumi, SA | 1 |
| Jahanshiri, Z | 1 |
| Ghadimi, F | 1 |
| Rodrigues, CF | 1 |
| Mohammadi, SR | 1 |
| Roudbary, M | 2 |
| Dos Santos, AL | 1 |
| Aslani, P | 1 |
| Nikoomanesh, F | 1 |
| Qadir, MI | 1 |
| Bashir, H | 1 |
| Ahmad, MH | 1 |
| Hu, Q | 1 |
| Li, T | 1 |
| Yang, J | 1 |
| Peng, Y | 2 |
| Liu, Q | 1 |
| Liu, N | 1 |
| Bao, M | 1 |
| Bu, Q | 1 |
| Yang, R | 1 |
| Yang, Y | 1 |
| Wang, C | 2 |
| Li, N | 1 |
| Pakshir, K | 1 |
| Ghasemi, N | 1 |
| Zomorodian, K | 1 |
| Jowkar, F | 1 |
| Nouraei, H | 1 |
| Dastgheib, L | 1 |
| Fang, J | 1 |
| Huang, B | 1 |
| Ding, Z | 1 |
| Miyashiro, CA | 1 |
| Bernegossi, J | 1 |
| Bonifácio, BV | 1 |
| de Toledo, LG | 1 |
| Ramos, MAS | 1 |
| Bauab, TM | 1 |
| Chorilli, M | 1 |
| Khan, M | 1 |
| Paul, N | 1 |
| Fernandez, C | 1 |
| Wakelin, S | 1 |
| Shen Loo, Y | 1 |
| Yee Wong, T | 1 |
| Veettil, SK | 1 |
| Se Wong, P | 1 |
| Gopinath, D | 1 |
| Mooi Ching, S | 1 |
| Kunnath Menon, R | 1 |
| Ramírez-Amador, V | 2 |
| Patton, LL | 2 |
| Naglik, JR | 1 |
| Nittayananta, W | 2 |
| Iversen, DB | 1 |
| Hellfritzsch, M | 1 |
| Stage, TB | 1 |
| Aabenhus, RM | 1 |
| Lind, BS | 1 |
| Pottegård, A | 1 |
| Elkomy, MH | 1 |
| Elmowafy, M | 1 |
| Shalaby, K | 1 |
| Azmy, AF | 1 |
| Ahmad, N | 1 |
| Zafar, A | 1 |
| Eid, HM | 1 |
| Tamai, IA | 1 |
| Pakbin, B | 1 |
| Fasaei, BN | 1 |
| Makris, M | 1 |
| Fokoloros, C | 1 |
| Syrmali, A | 1 |
| Tsakiraki, Z | 1 |
| Damaskou, V | 1 |
| Papadavid, E | 1 |
| Kriem, S | 1 |
| Peretz, A | 1 |
| Blum, A | 1 |
| Zida, A | 1 |
| Yacouba, A | 1 |
| Bamba, S | 1 |
| Sangare, I | 1 |
| Sawadogo, M | 1 |
| Guiguemde, T | 1 |
| Kone, S | 1 |
| Traore, LK | 1 |
| Ouedraogo-Traore, R | 1 |
| Guiguemde, RT | 1 |
| Vipulanandan, G | 1 |
| Herrera, M | 1 |
| Wiederhold, NP | 2 |
| Li, X | 1 |
| Mintz, J | 1 |
| Wickes, BL | 2 |
| Kadosh, D | 1 |
| Break, TJ | 2 |
| Desai, JV | 2 |
| Natarajan, M | 2 |
| Ferre, EMN | 2 |
| Henderson, C | 2 |
| Zelazny, AM | 1 |
| Siebenlist, U | 2 |
| Hoekstra, WJ | 1 |
| Schotzinger, RJ | 2 |
| Garvey, EP | 2 |
| Lionakis, MS | 2 |
| Aslani, N | 1 |
| Janbabaei, G | 1 |
| Abastabar, M | 1 |
| Meis, JF | 1 |
| Babaeian, M | 1 |
| Khodavaisy, S | 1 |
| Boekhout, T | 1 |
| Badali, H | 1 |
| Zhou, Y | 1 |
| Liao, M | 1 |
| Zhu, C | 1 |
| Hu, Y | 1 |
| Tong, T | 1 |
| Peng, X | 1 |
| Li, M | 1 |
| Feng, M | 1 |
| Cheng, L | 1 |
| Ren, B | 1 |
| Zhou, X | 1 |
| Healey, KR | 1 |
| Zelazny, A | 1 |
| Yates, CM | 1 |
| Cohen, OJ | 1 |
| Perlin, DS | 1 |
| Khedri, S | 1 |
| Santos, ALS | 1 |
| Hadighi, R | 1 |
| Falahati, M | 1 |
| Farahyar, S | 1 |
| Khoshmirsafa, M | 1 |
| Kalantari, S | 1 |
| Aitken-Saavedra, J | 1 |
| Lund, RG | 1 |
| González, J | 1 |
| Huenchunao, R | 1 |
| Perez-Vallespir, I | 1 |
| Morales-Bozo, I | 1 |
| Urzúa, B | 1 |
| Tarquinio, SC | 1 |
| Maturana-Ramírez, A | 1 |
| Martos, J | 1 |
| Fernandez-Ramires, R | 1 |
| Molina-Berríos, A | 1 |
| Goulart, LS | 1 |
| Souza, WWR | 1 |
| Vieira, CA | 1 |
| Lima, JS | 1 |
| Olinda, RA | 1 |
| Araújo, C | 1 |
| Castillo-Martínez, NA | 1 |
| Mouriño-Pérez, RR | 1 |
| Cornejo-Bravo, JM | 1 |
| Gaitán-Cepeda, LA | 2 |
| Quindós, G | 4 |
| Gil-Alonso, S | 1 |
| Marcos-Arias, C | 1 |
| Sevillano, E | 1 |
| Mateo, E | 1 |
| Jauregizar, N | 1 |
| Eraso, E | 2 |
| Moldenhauer, I | 1 |
| Pliquett, RU | 1 |
| Kreft, B | 2 |
| Sunderkötter, C | 1 |
| Gumussoy, M | 1 |
| Kucuk, U | 1 |
| Maurya, V | 1 |
| Srivastava, A | 1 |
| Mishra, J | 1 |
| Venkatesh, V | 1 |
| Sanitá, PV | 1 |
| Mima, EG | 1 |
| Pavarina, AC | 1 |
| Jorge, JH | 1 |
| Machado, AL | 1 |
| Vergani, CE | 1 |
| Kamikawa, Y | 1 |
| Mori, Y | 1 |
| Nagayama, T | 1 |
| Fujisaki, J | 1 |
| Hirabayashi, D | 1 |
| Sakamoto, R | 1 |
| Hamada, T | 1 |
| Sugihara, K | 1 |
| Yong, X | 1 |
| Li, R | 1 |
| Liu, W | 2 |
| Qin, Q | 1 |
| Zhang, L | 1 |
| Liu, Z | 1 |
| Liang, H | 1 |
| Tao, R | 1 |
| Anil, S | 2 |
| Hashem, M | 1 |
| Vellappally, S | 1 |
| Patil, S | 1 |
| Bandara, HM | 1 |
| Samaranayake, LP | 7 |
| Pereira, Tdos S | 1 |
| Silva Alves, Jde F | 1 |
| Gomes, CC | 1 |
| Rocha do Nascimento, A | 1 |
| Stoianoff, MA | 1 |
| Gomez, RS | 1 |
| Kong, EF | 1 |
| Kucharíková, S | 1 |
| Van Dijck, P | 1 |
| Peters, BM | 1 |
| Shirtliff, ME | 1 |
| Jabra-Rizk, MA | 3 |
| Lewis, M | 1 |
| Gabrielli, E | 1 |
| Roselletti, E | 1 |
| Luciano, E | 1 |
| Sabbatini, S | 1 |
| Mosci, P | 1 |
| Pericolini, E | 1 |
| Sharifzadeh, A | 1 |
| Khosravi, AR | 2 |
| Shokri, H | 1 |
| Sharafi, G | 1 |
| Ellepola, AN | 6 |
| Jayathilake, JA | 1 |
| Sharma, PN | 1 |
| Khan, ZU | 1 |
| Al-Shayyab, MH | 1 |
| Abu-Hammad, OA | 1 |
| Al-Omiri, MK | 1 |
| Dar-Odeh, NS | 2 |
| Astvad, K | 1 |
| Johansen, HK | 1 |
| Høiby, N | 1 |
| Steptoe, P | 1 |
| Ishøy, T | 1 |
| Wang, L | 1 |
| Mei, H | 1 |
| Shen, Y | 1 |
| Lv, G | 1 |
| Zeng, R | 1 |
| Zhan, P | 1 |
| Li, D | 1 |
| Vila, TV | 1 |
| Chaturvedi, AK | 1 |
| Rozental, S | 1 |
| Lopez-Ribot, JL | 11 |
| Salari, S | 1 |
| Mousavi, SA | 1 |
| Nikbakht-Brojeni, GH | 1 |
| Tati, S | 1 |
| Davidow, P | 1 |
| McCall, A | 1 |
| Hwang-Wong, E | 1 |
| Rojas, IG | 1 |
| Cormack, B | 1 |
| Edgerton, M | 2 |
| Vidya, KM | 1 |
| Rao, UK | 1 |
| Liu, H | 1 |
| Owotade, FJ | 1 |
| Lagman, R | 1 |
| Davis, M | 1 |
| LeGrand, S | 1 |
| Walsh, D | 1 |
| Parala, A | 1 |
| Gamier, P | 1 |
| Cothren, B | 1 |
| Cheema, B | 1 |
| Gopal, S | 1 |
| Rybicki, L | 1 |
| Minea, B | 1 |
| Nastasa, V | 1 |
| Kolecka, A | 1 |
| Mares, M | 2 |
| Marangoci, N | 1 |
| Rosca, I | 1 |
| Pinteala, M | 1 |
| Hancianu, M | 1 |
| Rençber, S | 1 |
| Karavana, SY | 1 |
| Yılmaz, FF | 1 |
| Eraç, B | 1 |
| Nenni, M | 1 |
| Özbal, S | 1 |
| Pekçetin, Ç | 1 |
| Gurer-Orhan, H | 1 |
| Hoşgör-Limoncu, M | 1 |
| Güneri, P | 1 |
| Ertan, G | 1 |
| Kumar, S | 1 |
| Minz, M | 1 |
| Sinha, SK | 1 |
| Vaiphei, K | 1 |
| Sharma, A | 1 |
| Singh, S | 1 |
| Kenwar, DB | 1 |
| Nadagir, SD | 1 |
| Chunchanur, SK | 1 |
| Halesh, LH | 1 |
| Yasmeen, K | 1 |
| Chandrasekhar, MR | 1 |
| Patil, BS | 1 |
| Randolph, C | 1 |
| Kaplan, C | 1 |
| Fraser, B | 1 |
| Su, CW | 1 |
| Gaskie, S | 1 |
| Jamieson, B | 1 |
| Triezenberg, D | 1 |
| Umamaheswari, K | 2 |
| Menon, T | 2 |
| Pinto, E | 1 |
| Ribeiro, IC | 1 |
| Ferreira, NJ | 1 |
| Fortes, CE | 1 |
| Fonseca, PA | 1 |
| Figueiral, MH | 1 |
| da Costa, KR | 1 |
| Ferreira, JC | 1 |
| Komesu, MC | 1 |
| Candido, RC | 1 |
| Hamza, OJ | 1 |
| Matee, MI | 1 |
| Brüggemann, RJ | 1 |
| Moshi, MJ | 1 |
| Simon, EN | 1 |
| Mugusi, F | 1 |
| Mikx, FH | 1 |
| van der Lee, HA | 1 |
| Verweij, PE | 1 |
| van der Ven, AJ | 1 |
| Jewtuchowicz, VM | 1 |
| Mujica, MT | 1 |
| Brusca, MI | 1 |
| Sordelli, N | 1 |
| Malzone, MC | 1 |
| Pola, SJ | 1 |
| Iovannitti, CA | 1 |
| Rosa, AC | 1 |
| Yehia, SA | 2 |
| El-Gazayerly, ON | 2 |
| Basalious, EB | 2 |
| Lester, LJ | 1 |
| Brantley, JS | 1 |
| Kelso, RL | 1 |
| Kelly, BC | 1 |
| Petitt, MS | 1 |
| Wilkerson, MG | 1 |
| Sánchez Vargas, LO | 1 |
| Carrillo-Muñoz, AJ | 2 |
| Aguirre, JM | 1 |
| Pankhurst, CL | 2 |
| Deuschle, P | 1 |
| Isham, N | 1 |
| Ghannoum, MA | 3 |
| Sholapurkar, AA | 1 |
| Pai, KM | 1 |
| Rao, S | 1 |
| Oehme, A | 1 |
| Lübbert, C | 1 |
| Marsch, WC | 1 |
| Kekulé, AS | 1 |
| Sun, J | 1 |
| Qi, C | 1 |
| Lafleur, MD | 1 |
| Qi, QG | 1 |
| Siikala, E | 1 |
| Rautemaa, R | 2 |
| Richardson, M | 1 |
| Saxen, H | 1 |
| Bowyer, P | 1 |
| Sanglard, D | 6 |
| Kothavade, RJ | 1 |
| Oberai, CM | 1 |
| Valand, AG | 1 |
| Panthaki, MH | 1 |
| McManus, BA | 1 |
| McGovern, E | 1 |
| Moran, GP | 2 |
| Healy, CM | 1 |
| Nunn, J | 1 |
| Fleming, P | 1 |
| Costigan, C | 1 |
| Sullivan, DJ | 3 |
| Coleman, DC | 4 |
| Nairy, HM | 1 |
| Charyulu, NR | 1 |
| Shetty, VA | 1 |
| Prabhakara, P | 1 |
| Nweze, EI | 1 |
| Ogbonnaya, UL | 1 |
| Chen, YL | 1 |
| Brand, A | 1 |
| Morrison, EL | 1 |
| Silao, FG | 1 |
| Bigol, UG | 1 |
| Malbas, FF | 1 |
| Nett, JE | 1 |
| Andes, DR | 1 |
| Solis, NV | 1 |
| Filler, SG | 3 |
| Averette, A | 1 |
| Heitman, J | 1 |
| Mayercik, VA | 1 |
| Eller, AW | 1 |
| Pihlblad, MS | 1 |
| Mohamed, SP | 1 |
| Muzzammil, S | 1 |
| Pramod, KT | 1 |
| Yan, Z | 1 |
| Young, AL | 1 |
| Hua, H | 2 |
| Wu, CJ | 1 |
| Lee, HC | 1 |
| Yang, YL | 3 |
| Chang, CM | 1 |
| Chen, HT | 1 |
| Lin, CC | 1 |
| Lee, NY | 1 |
| Chu, WL | 1 |
| Hsieh, LY | 1 |
| Wang, YL | 1 |
| Lauderale, TL | 1 |
| Tseng, FC | 1 |
| Ko, NY | 1 |
| Ko, WC | 1 |
| Lo, HJ | 3 |
| Gallè, F | 1 |
| Sanguinetti, M | 1 |
| Colella, G | 1 |
| Di Onofrio, V | 1 |
| Torelli, R | 1 |
| Rossano, F | 1 |
| Liguori, G | 1 |
| Hayama, K | 1 |
| Ishibashi, H | 3 |
| Ishijima, SA | 1 |
| Niimi, K | 1 |
| Tansho, S | 1 |
| Ono, Y | 1 |
| Monk, BC | 1 |
| Holmes, AR | 1 |
| Harding, DR | 1 |
| Cannon, RD | 1 |
| Abe, S | 3 |
| Min, D | 1 |
| Dominessy, C | 1 |
| Oliveira, E | 1 |
| Scwingel, AR | 1 |
| Barcessat, AR | 1 |
| Núñez, SC | 1 |
| Ribeiro, MS | 1 |
| Moris, DV | 1 |
| Melhem, MSC | 1 |
| Martins, MA | 1 |
| Souza, LR | 1 |
| Kacew, S | 1 |
| Szeszs, MW | 1 |
| Carvalho, LR | 1 |
| Pimenta-Rodrigues, MV | 1 |
| Berghs, HAM | 1 |
| Mendes, RP | 1 |
| Salim, N | 1 |
| Moore, C | 1 |
| Silikas, N | 1 |
| Satterthwaite, J | 1 |
| Castro, LÁ | 1 |
| Álvarez, MI | 1 |
| Martínez, E | 1 |
| Salvia, AC | 1 |
| Figueiredo, MS | 1 |
| Braga, JA | 1 |
| Pereira, DF | 1 |
| Brighenti, FL | 1 |
| Koga-Ito, CY | 1 |
| Westbrook, SD | 1 |
| Kirkpatrick, WR | 17 |
| Freytes, CO | 1 |
| Toro, JJ | 1 |
| Patterson, TF | 22 |
| Redding, SW | 13 |
| Epstein, JB | 3 |
| Gorsky, M | 1 |
| Caldwell, J | 1 |
| Pagani, JL | 4 |
| Chave, JP | 4 |
| Casjka, C | 1 |
| Glauser, MP | 3 |
| Bille, J | 6 |
| Martinez, M | 3 |
| Coco, BJ | 5 |
| Bachmann, SP | 4 |
| Koks, CH | 3 |
| Crommentuyn, KM | 2 |
| Mathôt, RA | 2 |
| Mulder, JW | 1 |
| Meenhorst, PL | 2 |
| Beijnen, JH | 3 |
| Bult, A | 1 |
| Villanueva, A | 1 |
| Gotuzzo, E | 1 |
| Arathoon, EG | 1 |
| Noriega, LM | 2 |
| Kartsonis, NA | 1 |
| Lupinacci, RJ | 1 |
| Smietana, JM | 1 |
| DiNubile, MJ | 1 |
| Sable, CA | 1 |
| Barchiesi, F | 7 |
| Maracci, M | 1 |
| Radi, B | 1 |
| Arzeni, D | 3 |
| Baldassarri, I | 1 |
| Giacometti, A | 2 |
| Scalise, G | 7 |
| Goins, RA | 1 |
| Ascher, D | 1 |
| Waecker, N | 1 |
| Arnold, J | 1 |
| Moorefield, E | 1 |
| Shepherd, J | 1 |
| Pérez Prim, FJ | 1 |
| Vila, I | 1 |
| Blignaut, E | 2 |
| Koc, M | 1 |
| Aktas, E | 1 |
| Maebashi, K | 1 |
| Kudoh, M | 1 |
| Nishiyama, Y | 1 |
| Makimura, K | 1 |
| Kamai, Y | 1 |
| Uchida, K | 2 |
| Yamaguchi, H | 3 |
| Myoken, Y | 2 |
| Sugata, T | 2 |
| Fujita, Y | 1 |
| Mikami, Y | 2 |
| Kiriyama, T | 1 |
| Makarova, NU | 1 |
| Pokrowsky, VV | 1 |
| Kravchenko, AV | 1 |
| Serebrovskaya, LV | 1 |
| James, MJ | 1 |
| McNeil, MM | 2 |
| Lasker, BA | 2 |
| Warnock, DW | 3 |
| Reiss, E | 2 |
| Shehabi, AA | 1 |
| Takakura, N | 1 |
| Sato, Y | 1 |
| Oshima, H | 2 |
| Tsarev, VN | 1 |
| Dmitrieva, LA | 1 |
| Tapia, C | 1 |
| González, P | 1 |
| Pereira, A | 1 |
| Pérez, J | 1 |
| Palavecino, E | 1 |
| Dahiya, MC | 2 |
| Dahiya, RS | 1 |
| Eng, TY | 1 |
| Sadkowski, LC | 1 |
| Fothergill, AW | 12 |
| Waite, A | 1 |
| Rinaldi, MG | 18 |
| Thomas, CR | 2 |
| Kreuter, A | 1 |
| Teichmann, M | 1 |
| Stuecker, M | 1 |
| Altmeyer, P | 1 |
| Tietz, HJ | 1 |
| Brockmeyer, NH | 2 |
| Lattif, AA | 1 |
| Banerjee, U | 1 |
| Prasad, R | 1 |
| Biswas, A | 1 |
| Wig, N | 1 |
| Sharma, N | 1 |
| Haque, A | 1 |
| Gupta, N | 1 |
| Baquer, NZ | 1 |
| Mukhopadhyay, G | 1 |
| Truelove, EL | 1 |
| Hanson-Huggins, K | 1 |
| Mancl, LA | 1 |
| Chen, A | 1 |
| Press, OW | 1 |
| Petersdorf, SH | 1 |
| Fritsche, TR | 1 |
| Epstein, JD | 1 |
| Oude Lashof, AM | 1 |
| De Bock, R | 1 |
| Herbrecht, R | 1 |
| de Pauw, BE | 1 |
| Krcmery, V | 3 |
| Aoun, M | 1 |
| Akova, M | 4 |
| Cohen, J | 1 |
| Siffnerová, H | 1 |
| Egyed, M | 1 |
| Ellis, M | 1 |
| Marinus, A | 1 |
| Sylvester, R | 1 |
| Kullberg, BJ | 1 |
| Oliver, RJ | 1 |
| Dhaliwal, HS | 1 |
| Theaker, ED | 1 |
| Pemberton, MN | 1 |
| Petraitis, V | 2 |
| Petraitiene, R | 2 |
| Kelaher, AM | 1 |
| Sarafandi, AA | 1 |
| Sein, T | 2 |
| Mickiene, D | 1 |
| Bacher, J | 2 |
| Groll, AH | 2 |
| Walsh, TJ | 3 |
| Cha, R | 1 |
| Sobel, JD | 4 |
| Burn, AK | 1 |
| McCarthy, DI | 2 |
| Romano, C | 1 |
| Ghilardi, A | 1 |
| Carcagnì, MR | 1 |
| De Aloe, GB | 1 |
| Ruesga, M | 1 |
| Alonso, R | 1 |
| del Valle, O | 1 |
| Hernández-Molina, JM | 1 |
| McNicholas, P | 1 |
| Loebenberg, D | 1 |
| Santos, P | 1 |
| Pinjon, E | 1 |
| Jackson, CJ | 1 |
| Kelly, SL | 1 |
| Moran, G | 1 |
| Hung, CC | 2 |
| Lauderdale, TL | 2 |
| McDonald, LC | 1 |
| Hsiao, CF | 1 |
| Cheng, HH | 2 |
| Ho, YA | 1 |
| Yamamoto, T | 1 |
| Ueta, E | 1 |
| Kamatani, T | 1 |
| Osaki, T | 1 |
| Tekeli, A | 1 |
| Koyuncu, E | 1 |
| Dolapci, I | 1 |
| Guven, GS | 1 |
| Sahin, GO | 1 |
| Uzun, O | 3 |
| Nicolatou-Galitis, O | 1 |
| Velegraki, A | 1 |
| Sotiropoulou-Lontou, A | 1 |
| Dardoufas, K | 1 |
| Kouloulias, V | 1 |
| Kyprianou, K | 1 |
| Kolitsi, G | 1 |
| Skarleas, C | 1 |
| Pissakas, G | 1 |
| Papanicolaou, VS | 1 |
| Kouvaris, J | 1 |
| Sulica, L | 1 |
| Oliveira, ER | 1 |
| Dalle, S | 1 |
| Skowron, F | 1 |
| Ronger-Savlé, S | 1 |
| Balme, B | 1 |
| Thomas, L | 1 |
| Koray, M | 1 |
| Ak, G | 1 |
| Kurklu, E | 1 |
| Issever, H | 1 |
| Tanyeri, H | 1 |
| Kulekci, G | 1 |
| Guc, U | 1 |
| Hartung de Capriles, C | 1 |
| Mata-Essayag, S | 1 |
| Pérez, C | 1 |
| Colella, MT | 1 |
| Roselló, A | 1 |
| Olaizola, C | 1 |
| Abate, SM | 1 |
| Goldman, M | 2 |
| Cloud, GA | 1 |
| Wade, KD | 1 |
| Reboli, AC | 1 |
| Fichtenbaum, CJ | 3 |
| Hafner, R | 1 |
| Powderly, WG | 3 |
| Wheat, LJ | 2 |
| Stein, DK | 1 |
| Dismukes, WE | 1 |
| Bozzette, SA | 1 |
| Kuriyama, T | 1 |
| Williams, DW | 1 |
| Bagg, J | 3 |
| Coulter, WA | 2 |
| Ready, D | 1 |
| Lewis, MA | 4 |
| Lilly, EA | 1 |
| Shetty, KV | 1 |
| Leigh, JE | 1 |
| Cheeks, C | 1 |
| Fidel, PL | 1 |
| Li, SY | 1 |
| Chen, KW | 1 |
| Chiou, CS | 1 |
| Wang, TH | 1 |
| Vazquez, JA | 4 |
| Skiest, DJ | 2 |
| Nieto, L | 1 |
| Northland, R | 1 |
| Sanne, I | 1 |
| Gogate, J | 1 |
| Greaves, W | 1 |
| Isaacs, R | 2 |
| Shetty, K | 1 |
| Zhao, M | 2 |
| Zhou, ZT | 2 |
| Zhang, WD | 1 |
| Agha-Hosseini, F | 1 |
| Brown, RS | 1 |
| Bailey, J | 1 |
| Winfree, WJ | 1 |
| Harden, S | 1 |
| Botes, ME | 1 |
| Nieman, HL | 1 |
| Vigneswaran, N | 1 |
| Anderson, GB | 1 |
| Kofla, G | 1 |
| Ruhnke, M | 8 |
| Lyon, JP | 2 |
| de Resende, MA | 2 |
| Anstead, GM | 1 |
| Graybill, JR | 2 |
| Reynes, J | 5 |
| Ward, D | 1 |
| Hare, R | 1 |
| Boparai, N | 1 |
| Hu, W | 1 |
| Ninomiya, K | 1 |
| Maruyama, N | 1 |
| Chen, FC | 1 |
| Lin, M | 1 |
| Rodríguez-Tudela, JL | 7 |
| Almirante, B | 1 |
| Rodríguez-Pardo, D | 1 |
| Laguna, F | 6 |
| Donnelly, JP | 1 |
| Mouton, JW | 1 |
| Pahissa, A | 1 |
| Cuenca-Estrella, M | 1 |
| Liu, X | 1 |
| Wang, XZ | 1 |
| Fan, B | 1 |
| Liu, LG | 1 |
| Hu, XY | 1 |
| Li, RY | 1 |
| Wei, Y | 1 |
| Wan, Z | 1 |
| Deng, XL | 1 |
| Corvò, R | 1 |
| Amichetti, M | 1 |
| Ascarelli, A | 1 |
| Arcangeli, G | 1 |
| Buffoli, A | 1 |
| Cellini, N | 1 |
| Cionini, L | 1 |
| De Renzis, C | 1 |
| Emiliani, E | 1 |
| Franchini, P | 1 |
| Gabriele, P | 1 |
| Gobitti, C | 1 |
| Grillo Ruggieri, F | 1 |
| Bertoni, F | 1 |
| Magrini, SM | 1 |
| Marmiroli, L | 1 |
| Orsatti, M | 1 |
| Panizza, GM | 1 |
| Tordiglione, M | 1 |
| Ziccarelli, L | 1 |
| Gava, A | 1 |
| Zorat, PL | 1 |
| Ghelfi, R | 1 |
| Serra, GF | 1 |
| Vitale, V | 1 |
| Diz Dios, P | 2 |
| Ocampo Hermida, A | 1 |
| Miralles Alvarez, C | 1 |
| Iglesias Martin, I | 1 |
| Otero Varela, I | 1 |
| Schaffner, A | 1 |
| Schaffner, M | 1 |
| Quirk, PC | 1 |
| Osborne, PJ | 1 |
| Walsh, LJ | 1 |
| Viard, JP | 1 |
| Hennequin, C | 1 |
| Fortineau, N | 1 |
| Pertuiset, N | 1 |
| Rothschild, C | 1 |
| Zylberberg, H | 1 |
| Just-Nübling, G | 3 |
| Diz Dios, PD | 1 |
| Alvarez Alvarez, J | 1 |
| Fernández Feijoo, J | 1 |
| Castro Ferreiro, M | 1 |
| Arikan, A | 2 |
| Kulak, Y | 2 |
| Kadir, T | 1 |
| Flynn, PM | 1 |
| Cunningham, CK | 1 |
| Kerkering, T | 2 |
| San Jorge, AR | 1 |
| Peters, VB | 1 |
| Pitel, PA | 1 |
| Harris, J | 1 |
| Gilbert, G | 1 |
| Castagnaro, L | 1 |
| Robinson, P | 1 |
| Coppola, S | 2 |
| Angarano, G | 1 |
| Montagna, MT | 1 |
| Congedo, P | 1 |
| Monno, L | 1 |
| Bellisario, A | 1 |
| Pastore, G | 1 |
| Hollis, RJ | 2 |
| McGough, DA | 2 |
| Pfaller, MA | 6 |
| Johnson, EM | 1 |
| Luker, J | 1 |
| Porter, SR | 1 |
| Scully, C | 1 |
| Tiballi, RN | 1 |
| He, X | 1 |
| Zarins, LT | 1 |
| Revankar, SG | 5 |
| Kauffman, CA | 1 |
| Garcia-Hermoso, D | 1 |
| Dromer, F | 2 |
| Improvisi, L | 2 |
| Provost, F | 1 |
| Dupont, B | 5 |
| Laufen, H | 2 |
| Yeates, RA | 2 |
| Zimmermann, T | 2 |
| de los Reyes, C | 1 |
| Newman, SL | 1 |
| Flanigan, TP | 2 |
| Fisher, A | 1 |
| Stein, M | 1 |
| Vigilante, K | 1 |
| White, A | 1 |
| Goetz, MB | 2 |
| Martínez-Suárez, JV | 7 |
| Adrados, M | 1 |
| Eigler, A | 1 |
| Tennagen, I | 1 |
| Geiseler, B | 1 |
| Engelmann, E | 2 |
| Trautmann, M | 4 |
| Imbert-Bernard, C | 1 |
| Valentin, A | 1 |
| Mallié, M | 4 |
| Bastide, JM | 4 |
| Dewsnup, DH | 1 |
| Stevens, DA | 4 |
| Dunsche, A | 1 |
| Kerscher, A | 1 |
| Terheyden, H | 1 |
| Sahly, H | 1 |
| Metzger, S | 2 |
| Jäger, H | 1 |
| Hofmann, H | 2 |
| Sow, PS | 1 |
| Diop, BM | 1 |
| Ndiaye, I | 1 |
| Faye, MA | 1 |
| Coll-Seck, AM | 1 |
| Rhine-Chalberg, J | 3 |
| Smith, J | 3 |
| Farinacci, G | 2 |
| Greenspan, D | 4 |
| Chavanet, P | 1 |
| Lopez, J | 1 |
| Grappin, M | 1 |
| Bonnin, A | 1 |
| Duong, M | 1 |
| Waldner, A | 1 |
| Buisson, M | 1 |
| Camerlynck, P | 1 |
| Portier, H | 1 |
| Delibalta, N | 1 |
| Corzo Delgado, JE | 1 |
| Lozano de León, F | 1 |
| Aretio Najarro, R | 1 |
| Martín Mazuelos, E | 1 |
| Akalin, HE | 2 |
| Hayran, M | 2 |
| Tekuzman, G | 1 |
| Kansu, E | 1 |
| Aslan, S | 1 |
| Telatar, H | 1 |
| Millon, L | 2 |
| Manteaux, A | 2 |
| Reboux, G | 2 |
| Drobacheff, C | 2 |
| Monod, M | 3 |
| Barale, T | 2 |
| Michel-Briand, Y | 1 |
| Vuffray, A | 1 |
| Durussel, C | 2 |
| Boerlin, P | 2 |
| Boerlin-Petzold, F | 2 |
| Marchisio, P | 1 |
| Principi, N | 1 |
| Hernández-Sampelayo, T | 1 |
| Troke, PF | 2 |
| Hitchcock, CA | 1 |
| Marriott, DJ | 1 |
| Jones, PD | 1 |
| Hoy, JF | 1 |
| Speed, BR | 1 |
| Harkness, JL | 1 |
| Grant, C | 1 |
| Morthland, V | 1 |
| Redding, S | 1 |
| Rinaldi, M | 1 |
| Fothergill, A | 1 |
| Pfaller, M | 1 |
| De Wit, S | 4 |
| Goossens, H | 2 |
| Clumeck, N | 4 |
| Morbiducci, V | 1 |
| Ancarani, F | 2 |
| Pons, V | 2 |
| Debruin, M | 1 |
| Glatt, AE | 1 |
| Polanco, AM | 2 |
| van der Bijl, P | 1 |
| Arendorf, TM | 1 |
| Azón-Masoliver, A | 1 |
| Vilaplana, J | 1 |
| Heinic, GS | 1 |
| MacPhail, LA | 1 |
| Dodd, CL | 1 |
| Stringari, S | 1 |
| Strull, WM | 1 |
| Hollander, H | 1 |
| Cameron, ML | 1 |
| Schell, WA | 2 |
| Bruch, S | 1 |
| Bartlett, JA | 2 |
| Waskin, HA | 1 |
| Perfect, JR | 2 |
| Bissell, V | 1 |
| Felix, DH | 1 |
| Wray, D | 2 |
| Paterson, AJ | 1 |
| Lamey, PJ | 5 |
| Nolan, A | 1 |
| Rademaker, M | 1 |
| Stark, A | 1 |
| Dale, B | 1 |
| Toolis, F | 1 |
| Diz, P | 1 |
| Ocampo, A | 2 |
| Miralles, C | 1 |
| Otero, I | 1 |
| Iglesias, I | 2 |
| Martínez, C | 1 |
| Ng, TT | 1 |
| Denning, DW | 3 |
| Sanguineti, A | 1 |
| Carmichael, JK | 1 |
| Campbell, K | 1 |
| Huijgens, PC | 1 |
| van Loenen, AC | 1 |
| Simoons-Smit, AM | 1 |
| Prooy, E | 1 |
| Ossenkoppele, GJ | 1 |
| Del Poeta, M | 1 |
| Maenza, JR | 2 |
| Keruly, JC | 2 |
| Moore, RD | 2 |
| Chaisson, RE | 1 |
| Merz, WG | 4 |
| Gallant, JE | 3 |
| Newton, JA | 1 |
| Tasker, SA | 1 |
| Bone, WD | 1 |
| Oldfield, EC | 1 |
| Olson, PE | 1 |
| Nguyen, MT | 1 |
| Wallace, MR | 1 |
| Le Guennec, R | 1 |
| Pujol, C | 1 |
| Janbon, F | 2 |
| Kuchler, K | 1 |
| Ischer, F | 1 |
| Espinel-Ingroff, A | 2 |
| Zingman, BS | 2 |
| Quereda, C | 1 |
| Giner, C | 1 |
| Sánchez-Sousa, A | 1 |
| Pereira, E | 1 |
| Navas, E | 1 |
| Fortún, J | 1 |
| Guerrero, A | 1 |
| Baquero, F | 1 |
| Finlay, PM | 1 |
| Richardson, MD | 1 |
| Robertson, AG | 1 |
| Ransier, A | 1 |
| Lunn, R | 1 |
| Chin, E | 1 |
| Jacobson, JJ | 1 |
| Le, N | 1 |
| Reece, D | 1 |
| Chryssanthou, E | 1 |
| Torssander, J | 1 |
| Petrini, B | 1 |
| Cartledge, JD | 8 |
| Midgley, J | 9 |
| Gazzard, BG | 8 |
| Najvar, LK | 1 |
| Luther, MF | 1 |
| Arranz-Caso, JA | 1 |
| Lopez-Pizarro, VM | 1 |
| Gomez-Herruz, P | 1 |
| García-Altozano, J | 1 |
| Martinez-Martinez, J | 1 |
| Goudet, J | 1 |
| Berenguer, J | 3 |
| Diaz-Guerra, TM | 3 |
| Ruiz-Diez, B | 1 |
| Bernaldo de Quiros, JC | 2 |
| Salonen, MA | 1 |
| Raustia, AM | 1 |
| Oikarinen, KS | 1 |
| Laurent, R | 1 |
| Eichel, M | 1 |
| Helm, EB | 2 |
| Stille, W | 2 |
| Wildfeuer, A | 1 |
| Dib, O | 1 |
| Sutton, DA | 1 |
| Dronda, F | 2 |
| Alonso-Sanz, M | 1 |
| Chaves, F | 1 |
| González-López, A | 1 |
| Valencia, E | 4 |
| McAtee, RK | 7 |
| Dib, OP | 3 |
| Lacassin, F | 1 |
| Damond, F | 1 |
| Chochillon, C | 1 |
| Longuet, P | 1 |
| Lebras, J | 1 |
| Vilde, JL | 1 |
| Leport, C | 1 |
| Tebbe, B | 1 |
| Boyvat, A | 1 |
| Geilen, CC | 1 |
| Wölfer, LU | 1 |
| Seibold, M | 3 |
| Orfanos, CE | 1 |
| Heald, AE | 1 |
| Cox, GM | 1 |
| Hata, K | 1 |
| Kimura, J | 1 |
| Miki, H | 1 |
| Toyosawa, T | 1 |
| Moriyama, M | 1 |
| Katsu, K | 1 |
| Phillips, P | 2 |
| Zemcov, J | 1 |
| Mahmood, W | 1 |
| Montaner, JS | 1 |
| Craib, K | 1 |
| Clarke, AM | 1 |
| Studena, V | 1 |
| Sycova, Z | 1 |
| Helpianska, L | 1 |
| Sorkovska, D | 1 |
| Pichna, P | 1 |
| Lacka, J | 1 |
| Hlavacova, E | 1 |
| Oravcova, E | 1 |
| Studena, M | 1 |
| Tumbarello, M | 2 |
| Caldarola, G | 2 |
| Tacconelli, E | 2 |
| Morace, G | 2 |
| Posteraro, B | 1 |
| Cauda, R | 2 |
| Ortona, L | 2 |
| Schmidt-Westhausen, A | 4 |
| Taylor, CB | 1 |
| Finlay, R | 1 |
| Richardson, C | 1 |
| Bunting, P | 1 |
| Welch, J | 1 |
| Napier, SS | 1 |
| MacDonald, DG | 2 |
| Romagnoli, MJ | 1 |
| Martins, MD | 3 |
| Rex, JH | 3 |
| Henman, MC | 2 |
| McCreary, CE | 1 |
| Harrington, BJ | 1 |
| Shanley, DB | 2 |
| Polo, R | 2 |
| Pulido, F | 1 |
| Dannaoui, E | 2 |
| Colin, S | 1 |
| Pichot, J | 1 |
| Piens, MA | 2 |
| Moreno, V | 1 |
| González-Lahoz, JM | 1 |
| Schuman, P | 2 |
| Capps, L | 1 |
| Peng, G | 1 |
| Vazquez, J | 1 |
| el-Sadr, W | 1 |
| Goldman, AI | 1 |
| Alston, B | 1 |
| Besch, CL | 1 |
| Vaughn, A | 1 |
| Thompson, MA | 1 |
| Cobb, MN | 1 |
| Lozada-Nur, F | 1 |
| McPhail, L | 1 |
| Tunkel, A | 1 |
| Johnson, CC | 1 |
| McCarty, J | 1 |
| Panzer, H | 1 |
| Levenstein, M | 1 |
| Barranco, A | 1 |
| Green, S | 1 |
| Messer, SA | 1 |
| Smith, JA | 1 |
| Prows, J | 1 |
| Bradley, LL | 1 |
| Wu, S | 1 |
| Guo, N | 1 |
| Hou, Y | 1 |
| Eliaszewicz, M | 1 |
| Pialoux, G | 1 |
| Fournier, S | 1 |
| Feuillie, V | 1 |
| Reichart, PA | 1 |
| Weigel, D | 1 |
| Pohle, HD | 1 |
| Silverman, S | 1 |
| Mayer, P | 1 |
| Tyler, M | 1 |
| Quivey, J | 1 |
| Pemberton, M | 1 |
| Sloan, P | 1 |
| Ariyaratnam, S | 1 |
| Thakker, NS | 1 |
| Thornhill, MH | 1 |
| Ustianowski, AP | 1 |
| Leake, H | 1 |
| Evans, S | 2 |
| Espejo Martínez, J | 1 |
| Alvarez Medina, MP | 1 |
| Sánchez Morales, S | 1 |
| Tillmann, I | 1 |
| Mertins, L | 1 |
| Barthel, B | 1 |
| Goos, M | 1 |
| Lozano-Chiu, M | 2 |
| White, TC | 3 |
| van Burik, JA | 1 |
| Bowden, RA | 1 |
| Petrou, M | 1 |
| Shanson, D | 1 |
| Alessandrini, F | 1 |
| Allegrini, F | 1 |
| Baldari, U | 1 |
| Cancellieri, C | 1 |
| Baily, G | 1 |
| Penk, A | 2 |
| Pittrow, L | 2 |
| Mücke, R | 2 |
| Kaben, U | 2 |
| Libera, T | 2 |
| Knauerhase, H | 2 |
| Ziegler, PG | 2 |
| Hamann, D | 2 |
| Strietzel, M | 2 |
| Fortun Abete, J | 1 |
| Hernanz Hermosa, JM | 1 |
| Lázaro Ochaita, P | 1 |
| Valcarcel, JP | 1 |
| Vazquez, E | 1 |
| Castro, M | 1 |
| Lacoste, V | 1 |
| Prat, C | 1 |
| Martin-Mazuelos, E | 2 |
| Aller, AI | 2 |
| Romero, MJ | 1 |
| Rodriguez Armijo, A | 1 |
| Gutierrez, MJ | 2 |
| Bernal, S | 2 |
| Montero, O | 2 |
| Penzak, SR | 1 |
| Gubbins, PO | 1 |
| Darouiche, RO | 1 |
| Hawkins, DA | 1 |
| Hood, S | 1 |
| Bonington, A | 1 |
| Evans, J | 1 |
| Denning, D | 1 |
| Valdez, H | 2 |
| Gripshover, BM | 2 |
| Salata, RA | 2 |
| Lederman, MM | 2 |
| Rogowska-Szadkowska, D | 1 |
| Wiercińska-Drapało, A | 1 |
| Borzuchowska, A | 1 |
| Prokopowicz, D | 1 |
| Arikan, S | 1 |
| Ozdemir, O | 1 |
| Erman, M | 1 |
| Gür, D | 2 |
| Unal, S | 1 |
| Hunter, KD | 1 |
| Gibson, J | 1 |
| Lockhart, P | 1 |
| Pithie, A | 1 |
| Del Prete, MS | 1 |
| Sinicco, A | 1 |
| Falconi Di Francesco, L | 1 |
| Pasticci, MB | 1 |
| Lamura, L | 1 |
| Nuzzo, MM | 1 |
| Burzacchini, F | 1 |
| Chiodo, F | 1 |
| De Beule, K | 1 |
| Frechette, G | 1 |
| Tchamouroff, S | 1 |
| Vandercam, B | 1 |
| Weitner, L | 1 |
| Hoepelman, A | 1 |
| Stingl, G | 1 |
| Clotet, B | 1 |
| Jandourek, A | 1 |
| Vaishampayan, JK | 1 |
| Metzgar, D | 1 |
| van Belkum, A | 1 |
| Field, D | 1 |
| Haubrich, R | 2 |
| Wills, C | 1 |
| Hilsenbeck, SG | 1 |
| Sanche, SE | 1 |
| Cantu, RA | 1 |
| Blomgren, J | 1 |
| Berggren, U | 1 |
| Jontell, M | 1 |
| Cross, LJ | 1 |
| Aitchison, T | 1 |
| Lee, LN | 1 |
| Hegener, P | 1 |
| Fätkenheuer, G | 1 |
| Diehl, V | 1 |
| Milan, EP | 2 |
| Burattini, MN | 1 |
| Kallás, EG | 1 |
| Fischmann, O | 1 |
| Costa, PR | 1 |
| Colombo, AL | 2 |
| Baqui, AA | 2 |
| Kelley, JI | 2 |
| Falkler, WA | 2 |
| Meiller, TF | 2 |
| Maesaki, S | 1 |
| Marichal, P | 1 |
| Hossain, MA | 1 |
| Vanden Bossche, H | 1 |
| Kohno, S | 1 |
| Hood, SV | 1 |
| Hollis, S | 1 |
| Percy, M | 1 |
| Atkinson, G | 1 |
| Williams, K | 1 |
| Martínez, MA | 1 |
| Zhang, H | 1 |
| Lu, Y | 1 |
| Liang, D | 1 |
| Perea, S | 3 |
| Nenoff, P | 1 |
| Taneva, E | 1 |
| Pfeil, B | 1 |
| Oswald, U | 1 |
| Haustein, UF | 1 |
| Plettenberg, A | 1 |
| Stoehr, A | 1 |
| Heise, W | 1 |
| Schlote, F | 1 |
| Sarnow, E | 1 |
| Migdal, M | 1 |
| La Valle, R | 1 |
| Franz, R | 1 |
| Morschhäuser, J | 2 |
| Lin, AL | 2 |
| Shi, Q | 2 |
| Johnson, DA | 2 |
| Yeh, CK | 2 |
| Elewski, B | 1 |
| Saag, MS | 1 |
| Fessel, WJ | 1 |
| Kaufman, CA | 1 |
| Merrill, KW | 1 |
| Ward, DJ | 1 |
| Moskovitz, BL | 1 |
| Thomas, C | 1 |
| Oleka, N | 1 |
| Guarnieri, JA | 1 |
| Lee, J | 1 |
| Brenner-Gati, L | 1 |
| Klausner, M | 1 |
| Meeks, VI | 1 |
| Zellars, RC | 1 |
| Caceres, MA | 1 |
| Bailey, CW | 2 |
| Fekete-Forgács, K | 1 |
| Kis, B | 1 |
| Nagy, G | 1 |
| Lenkey, B | 1 |
| Cowen, LE | 1 |
| Calabrese, D | 1 |
| Sirjusingh, C | 1 |
| Anderson, JB | 1 |
| Kohn, LM | 1 |
| Xu, J | 1 |
| Ramos, AR | 1 |
| Vilgalys, R | 1 |
| Mitchell, TG | 1 |
| Tintelnot, K | 2 |
| Haase, G | 1 |
| Bergmann, F | 1 |
| Staemmler, M | 1 |
| Franz, T | 1 |
| Naumann, D | 1 |
| Breidert, M | 1 |
| Schimmelpfennig, C | 1 |
| Kittner, T | 1 |
| Helwig, A | 1 |
| Ehninger, G | 1 |
| Schorling, SR | 1 |
| Kortinga, HC | 1 |
| Froschb, M | 1 |
| Mühlschlegel, FA | 1 |
| Taillandier, J | 1 |
| Esnault, Y | 1 |
| Alemanni, M | 1 |
| Koletar, S | 1 |
| Yiannoutsos, C | 1 |
| Holland, F | 1 |
| Pottage, J | 1 |
| Cohn, SE | 1 |
| Walawander, A | 1 |
| Frame, P | 1 |
| Feinberg, J | 1 |
| Saag, M | 1 |
| Van der Horst, C | 1 |
| Chow, CK | 1 |
| Matear, DW | 1 |
| Lawrence, HP | 1 |
| Gonzalez, CE | 1 |
| Piscitelli, S | 1 |
| Bacher, JD | 1 |
| Peter, J | 1 |
| Torres, R | 1 |
| Shetti, D | 1 |
| Katsov, V | 1 |
| Kligys, K | 1 |
| Lyman, CA | 2 |
| Zackin, R | 2 |
| Rajicic, N | 1 |
| Clemons, KV | 1 |
| Delèvaux, I | 1 |
| Bernard, N | 1 |
| Ramanampamonjy, R | 1 |
| Morlat, P | 1 |
| Lacoste, D | 1 |
| Bonnet, F | 1 |
| Bonnel, C | 1 |
| Deminière, C | 1 |
| Beylot, J | 1 |
| Masiá Canuto, M | 1 |
| Gutiérrez Rodero, F | 1 |
| Ortiz de la Tabla Ducasse, V | 1 |
| Hernández Aguado, I | 1 |
| Martín González, C | 1 |
| Sánchez Sevillano, A | 1 |
| Martín Hidalgo, A | 1 |
| Masci, JR | 1 |
| Schaufele, RL | 1 |
| Francesconi, A | 1 |
| Piscitelli, SC | 1 |
| Ohmit, SE | 1 |
| Klein, RS | 1 |
| Mayer, K | 1 |
| Duerr, A | 1 |
| Rampalo, A | 1 |
| Willis, AM | 1 |
| Fulton, CR | 1 |
| Hayes, JR | 1 |
| Bell, PM | 1 |
| Barr, D | 1 |
| Smart, T | 1 |
| Chandra, J | 1 |
| Mukherjee, PK | 1 |
| Leidich, SD | 1 |
| Faddoul, FF | 1 |
| Hoyer, LL | 1 |
| Douglas, LJ | 1 |
| Samaranayake, YH | 1 |
| Tsang, PC | 1 |
| Wong, KH | 1 |
| Yeung, KW | 1 |
| Hoetelmans, RM | 1 |
| Bonito, AJ | 1 |
| Shugars, DA | 1 |
| Wu, Y | 1 |
| Lu, DL | 1 |
| Elie, CM | 1 |
| Lott, TJ | 1 |
| Gallagher, L | 1 |
| Kuykendall, RJ | 1 |
| Kellum, ME | 1 |
| Pruitt, WR | 1 |
| Rimland, D | 1 |
| Brent, NB | 1 |
| Kumarasamy, N | 1 |
| Solomon, S | 1 |
| Thyagarajan, SP | 1 |
| Giammanco, GM | 2 |
| Pecorella, S | 2 |
| Distefano, S | 2 |
| Pecoraro, V | 2 |
| Milici, ME | 2 |
| Pizzo, G | 2 |
| Csajka, C | 1 |
| Décosterd, LA | 1 |
| Buclin, T | 1 |
| Fattinger, K | 1 |
| Biollaz, J | 1 |
| Kyo, T | 1 |
| Fujihara, M | 1 |
| Ruesga, MT | 1 |
| Haberland-Carrodeguas, C | 1 |
| Allen, CM | 1 |
| Beck, FM | 1 |
| Buesching, WJ | 1 |
| Koletar, SL | 2 |
| Sundstrom, P | 1 |
| Sant'Ana, Pde L | 1 |
| Martinez, R | 1 |
| Queiroz-Telles, F | 1 |
| Ferreira, MS | 1 |
| Alcântara, AP | 1 |
| Carvalho, MT | 1 |
| Keller, SM | 1 |
| Chetwynd, EM | 1 |
| Ives, TJ | 1 |
| Payne, PM | 1 |
| Edens-Bartholomew, N | 1 |
| Borg-von Zepelin, M | 1 |
| Niederhaus, T | 1 |
| Gross, U | 1 |
| Swindells, S | 1 |
| Balfour, HH | 1 |
| Martins, RS | 1 |
| Péreira, ES | 1 |
| Lima, SM | 1 |
| Senna, MI | 1 |
| Mesquita, RA | 1 |
| Santos, VR | 1 |
| Lefebvre, JL | 1 |
| Domenge, C | 1 |
| Branchesi, P | 1 |
| Crescenzi, G | 1 |
| Gallagher, PJ | 1 |
| Bennett, DE | 1 |
| Russell, RJ | 1 |
| Flint, SR | 1 |
| López-Dupla, M | 1 |
| Mora Sanz, P | 1 |
| Pintado García, V | 1 |
| Valencia Ortega, E | 1 |
| Uriol, PL | 1 |
| Khamashta, MA | 1 |
| Aguado, AG | 1 |
| Ravisse, P | 1 |
| André, D | 1 |
| Coker, RJ | 1 |
| Bell, D | 1 |
| Peters, BS | 1 |
| Murphy, SM | 1 |
| Wells, C | 1 |
| Lever, AM | 1 |
| Garber, GE | 1 |
| Samaranyake, LP | 1 |
| Gussenhoven, MJ | 1 |
| Haak, A | 1 |
| Peereboom-Wynia, JD | 1 |
| van 't Wout, JW | 1 |
| Dupouy-Camet, J | 1 |
| Paugam, A | 1 |
| Tourte-Schaefer, C | 1 |
| Greene, SI | 1 |
| Lang, OS | 1 |
| Smith, D | 1 |
| Boag, F | 1 |
| Gazzard, B | 1 |
| Tschechne, B | 1 |
| Brunkhorst, U | 1 |
| Dempe, S | 1 |
| Deicher, H | 1 |
| Gentschew, G | 1 |
| Meissner, K | 1 |
| Odewald, J | 1 |
| Staszewski, S | 1 |
| Koza, I | 1 |
| Hornikova, M | 1 |
| Fuchsberger, P | 1 |
| Spanik, S | 1 |
| Mardiak, J | 1 |
| Sufliarsky, J | 1 |
| Blahova, M | 1 |
| Savko, V | 1 |
| Migom, C | 1 |
| Willocks, L | 1 |
| Leen, CL | 3 |
| Brettle, RP | 1 |
| Urquhart, D | 1 |
| Russell, TB | 1 |
| Milne, LJ | 1 |
| Lim, SG | 1 |
| Lee, CA | 1 |
| Hales, M | 1 |
| O'Doherty, M | 1 |
| Winter, M | 1 |
| Kernoff, PB | 1 |
| Urbain, D | 1 |
| Rahir, F | 1 |
| Weerts, D | 2 |
| Lucatorto, FM | 1 |
| Franker, C | 1 |
| Hardy, WD | 1 |
| Chafey, S | 1 |
| Muńoz, P | 2 |
| Moreno, S | 2 |
| Bouza, E | 2 |
| Fox, R | 1 |
| Neal, KR | 1 |
| Ellis, ME | 2 |
| Mandal, BK | 2 |
| Kitchen, VS | 1 |
| Savage, M | 1 |
| Harris, JR | 1 |
| Meissner, GF | 1 |
| Russell, JA | 1 |
| Fass, RJ | 1 |
| Plouffe, JF | 1 |
| Garau, X | 1 |
| López Bernaldo de Quirós, JC | 1 |
| More, J | 1 |
| Meunier, F | 2 |
| Bodey, GP | 1 |
| Samonis, G | 1 |
| Rolston, K | 1 |
| Dunbar, EM | 1 |
| Esposito, R | 1 |
| Castagna, A | 1 |
| Uberti Foppa, C | 1 |
| Freeman, EM | 1 |
| Ansari, AM | 1 |
| Gould, IM | 1 |
| Douglas, JG | 1 |
| Hansen, E | 1 |
| Thorsen, S | 1 |
| Mathiesen, LR | 1 |
| Cajot, A | 1 |
| Dietrich, D | 1 |
| Matsushima, T | 1 |
| Ikeda, H | 1 |
| Tomizawa, S | 1 |
| Nakamura, J | 1 |
| Adachi, M | 1 |
| Kawanishi, M | 1 |
| Tanabe, J | 1 |
| Tano, Y | 1 |
| Martin, MV | 1 |
| Holmes, J | 1 |
| Clements, D | 1 |
| Drouhet, E | 2 |
| Budtz-Jørgensen, E | 1 |
| Holmstrup, P | 1 |
| Krogh, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Oral Candidiasis in HIV Infected Individuals in Tanzania[NCT00553137] | Phase 4 | 220 participants (Actual) | Interventional | 2006-11-30 | Completed | ||
| PROCAS: Study Observational Prospective and Multicenter to Determine the Clinic Effectiveness and the Safety of Caspofungin Acetate (CANCIDAS®) in the Treatment of Invader Fungal Infection[NCT00388167] | 320 participants (Anticipated) | Observational | 2004-03-31 | Completed | |||
| The Influence of Glutamine on the Side Effects of Chemo-radiation in Head and Neck Cancer Patients - A Randomized Controlled Trial[NCT02282839] | Phase 3 | 60 participants (Anticipated) | Interventional | 2015-01-31 | Recruiting | ||
| A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women[NCT00000744] | 400 participants | Interventional | Completed | ||||
| Incidence of Oral Candidiasis, Prevalence of Candida Dubliniensis in HIV Patients and In-vitro Azole Susceptibility. (I.C.O.N.I.C.)[NCT00692783] | 10 participants (Actual) | Observational | 2008-05-31 | Terminated (stopped due to Dr. Vindas completed his fellowship + low enrollment) | |||
| A Phase IV Randomized Study of the Use of Fluconazole as Chronic Suppressive Therapy Versus Episodic Therapy in HIV Positive Subjects With Recurrent Oropharyngeal Candidiasis[NCT00000951] | Phase 4 | 948 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
31 reviews available for fluconazole and Moniliasis, Oral
| Article | Year |
|---|---|
Comparison of topical antifungal agents for oral candidiasis treatment: a systematic review and meta-analysis.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Child; Fluconazole; Humans; Neoplasm Recurrence, Local | 2022 |
Efficacy of Flavonoids in Combating Fluconazole Resistant Oral Candidiasis.
Topics: Antifungal Agents; Azoles; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Flavonoids; Fluconaz | 2022 |
Efficacy of photodynamic therapy in the treatment of oral candidiasis: a systematic review and meta-analysis.
Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Miconazole; Nystatin; Photochemotherapy | 2023 |
Efficacy of antifungal drugs in the treatment of oral candidiasis: A Bayesian network meta-analysis.
Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Network Meta-Analysis; Pharmaceutical Pre | 2021 |
Antifungal agents in preventing oral candidiasis in clinical oncology: A network meta-analysis.
Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Medical Oncology; Network Meta-Analysis | 2021 |
Therapeutic tools for oral candidiasis: Current and new antifungal drugs.
Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulaf | 2019 |
Oral mycoses and other opportunistic infections in HIV: therapy and emerging problems - a workshop report.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Carrier State; | 2016 |
Clinical inquiries. What is the best treatment for oral thrush in healthy infants?
Topics: Administration, Oral; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis, Oral; Evidence-B | 2008 |
Candidiasis (oropharyngeal).
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Candidiasis, Oral; Fluconazole; HIV Infections | 2009 |
Candidiasis (oropharyngeal).
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Oral; Fluconazole; HIV Infections; Humans; Oro | 2012 |
Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis | 2002 |
Fungal susceptibility testing: where are we now?
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Cross Infection; Dose-Response Relationship, Drug; Dr | 2002 |
Fluconazole for the treatment of candidiasis: 15 years experience.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Candidiasis, Oral; Candidiasis, Vul | 2004 |
[Therapy of candidiasis and cryptococcosis in AIDS].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Cryptococc | 1994 |
Treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Oral; CD4-Positive T- | 1994 |
Itraconazole and fluconazole in oropharyngeal candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; | 1993 |
Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach.
Topics: AIDS-Related Opportunistic Infections; Candida; Candidiasis; Candidiasis, Oral; Drug Resistance, Mic | 1993 |
[Fluconazole (Diflucan): its clinical spectrum and development].
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Child; Cryptococ | 1997 |
[High-dose therapy with fluconazole > or = 800 mg/day. Review].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Dose-Respo | 1997 |
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Cand | 1995 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Chil | 1995 |
Preventing and treating azole-resistant oropharyngeal candidiasis in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microb | 1998 |
Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.
Topics: Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; | 1998 |
The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Genotype; HI | 2000 |
Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Clotrimazole; Drug Interactions; Drug | 2000 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agen | 2000 |
Fluconazole: a new option in the treatment of Candida mucositis and esophageal candidiasis.
Topics: Candidiasis; Candidiasis, Oral; Esophageal Diseases; Fluconazole; HIV Infections; Humans; Mouth Muco | 1992 |
Diagnosis and treatment of oral candidosis.
Topics: Antifungal Agents; Candidiasis, Oral; Chronic Disease; Fluconazole; HIV Infections; Humans; Immune T | 1991 |
Fluconazole treatment of fungal infections in the immunocompromised host.
Topics: Adolescent; Adult; Candidiasis, Oral; Child; Child, Preschool; Female; Fluconazole; Humans; Immune T | 1990 |
[Current progress in antifungal therapy: the value of fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningit | 1990 |
76 trials available for fluconazole and Moniliasis, Oral
| Article | Year |
|---|---|
Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
Topics: Adult; Aged; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Fluconazole; HIV Inf | 2008 |
Comparison of efficacy of fluconazole mouthrinse and clotrimazole mouthpaint in the treatment of oral candidiasis.
Topics: Antifungal Agents; Candidiasis, Oral; Chi-Square Distribution; Clotrimazole; Colony Count, Microbial | 2009 |
A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Female; Fluconazole; Gels; Humans; Male; Middle Aged; S | 2011 |
Antimicrobial photodynamic therapy in the treatment of oral candidiasis in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Female; Fluconaz | 2012 |
Fluconazole mouthrinses for oral candidiasis in postirradiation, transplant, and other patients.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Bone Marrow Transplantation; Candidiasis, Oral; C | 2002 |
Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis, Oral; Double-Blind Method; Drug Resistanc | 2002 |
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Ag | 2002 |
Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants.
Topics: Administration, Oral; Analysis of Variance; Antifungal Agents; Candidiasis, Oral; Dose-Response Rela | 2002 |
Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers.
Topics: Adult; Aged; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Fluconazole; Head an | 2003 |
Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer.
Topics: Adult; Aged; Candida; Candida tropicalis; Candidiasis, Oral; Female; Fluconazole; Head and Neck Neop | 2003 |
Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antibiotic Prophylaxis; Antifungal Ag | 2004 |
An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Oral; F | 2004 |
Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Antifungal Agents; Candida albicans; Candid | 2005 |
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; CD4 Lympho | 2005 |
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Candidi | 2006 |
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; | 2007 |
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis, Oral; Double-Blind Metho | 2008 |
Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias.
Topics: Adult; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Bacteremia; Candidi | 1995 |
Australian Dental Research Fund Trebitsch Scholarship. Efficacy of antifungal prophylaxis in bone marrow transplantation.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; | 1995 |
Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis.
Topics: Candida albicans; Candidiasis, Oral; CD4 Lymphocyte Count; Colony Count, Microbial; Fluconazole; HIV | 1995 |
Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group.
Topics: Administration, Oral; Adolescent; Candidiasis, Oral; Child; Child, Preschool; Double-Blind Method; D | 1995 |
Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconaz | 1995 |
Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candida; Candidiasis, Oral; Drug Resistance, Microbial; F | 1995 |
Pharmacokinetic optimization of the treatment of oral candidiasis with fluconazole: studies with a suspension.
Topics: Adult; Candidiasis, Oral; Cross-Over Studies; Female; Fluconazole; Humans; Male; Middle Aged; Saliva | 1995 |
[Indication for and effectiveness of fluconazole in oral candidiasis].
Topics: Candidiasis, Oral; Fluconazole; Humans; Mouth Neoplasms; Precancerous Conditions | 1994 |
[Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)].
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Female; Fluconazole; H | 1993 |
Comparison of three different treatment methods for generalized denture stomatitis.
Topics: Administration, Topical; Candida albicans; Candidiasis, Oral; Chlorhexidine; Denture, Complete, Uppe | 1994 |
Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome.
Topics: Adult; Candida; Candidiasis, Oral; Esophageal Diseases; Female; Fluconazole; Humans; Male; Middle Ag | 1994 |
Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole. Multicentre Study Group [corrected].
Topics: Administration, Oral; Adolescent; AIDS-Related Opportunistic Infections; Body Weight; Candida; Candi | 1994 |
Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Child; C | 1994 |
Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study.
Topics: Adult; Alkaline Phosphatase; Candidiasis, Oral; Double-Blind Method; Drug Administration Schedule; F | 1993 |
Single-dose versus 7 days of fluconazole treatment for oral candidiasis in human immunodeficiency virus-infected patients: a prospective, randomized pilot study.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis, Oral; Fluconazole; Humans; Pilot Projects | 1993 |
Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis, Oral; Clotrimazole; | 1993 |
Comparative trial of fluconazole and amphotericin in the treatment of denture stomatitis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Candidiasis, Oral; Erythema; Female; Fluconazole; Hu | 1993 |
A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Colony Count, | 1996 |
Effect of treatment of palatal inflammatory papillary hyperplasia with local and systemic antifungal agents accompanied by renewal of complete dentures.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Ch | 1996 |
Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis, Oral; Cyclodextrins; Drug Resistance, Mic | 1996 |
Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial.
Topics: Adult; Aged; Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Middle Aged; N | 1995 |
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, | 1996 |
Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral | 1997 |
Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Fluconazole; Hum | 1997 |
Clinical response to ketoconazole of HIV-related oral candidosis is predicted by Odds' relative growth method of susceptibility testing.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; H | 1997 |
[Use of fluconazole as antimycotic prophylaxis in radiotherapy of patients with head and neck tumors].
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Carcinoma, Squamous Cell; Fluconazo | 1997 |
Response to fluconazole and itraconazole of Candida spp. in denture stomatitis.
Topics: Binomial Distribution; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; | 1997 |
Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Or | 1998 |
Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral | 1998 |
A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Double-Blind Met | 1998 |
Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, | 1998 |
Random amplification of polymorphic DNA and microsatellite genotyping of pre- and posttreatment isolates of Candida spp. from human immunodeficiency virus-infected patients on different fluconazole regimens.
Topics: AIDS-Related Opportunistic Infections; Alleles; Antifungal Agents; Base Sequence; Candida; Candidias | 1998 |
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, | 1998 |
Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; DNA, | 1998 |
Fluconazole versus nystatin in the treatment of oral candidosis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Capsules; Dentures; Erythem | 1998 |
A comparison of fluconazole and itraconazole in the management of denture stomatitis: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Den | 1998 |
Fluconazole prophylaxis in patients with head and neck tumours undergoing radiation and radiochemotherapy.
Topics: Adult; Aged; Antifungal Agents; Candidiasis, Oral; Carcinoma, Squamous Cell; Combined Modality Thera | 1998 |
Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Colon | 1999 |
[Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Fluconaz | 1997 |
Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Cand | 1999 |
A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis, Oral; | 2000 |
Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidia | 2000 |
Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasi | 2000 |
The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
Topics: Analysis of Variance; Antifungal Agents; Bacterial Adhesion; Candida albicans; Candidiasis, Oral; Ch | 2001 |
Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, | 2001 |
Predictive value of HIV-1 viral load on risk for opportunistic infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Acti | 2002 |
A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis | 2002 |
Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidi | 1991 |
[Fluconazole in therapy of candidiasis of the oropharyngeal space in patients with HIV infection. Results of an open multicenter study of assessing the effectiveness and tolerance of fluconazole].
Topics: Administration, Oral; Adult; Aged; Candidiasis, Oral; Female; Fluconazole; HIV Infections; Humans; I | 1991 |
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Chronic Disease; Drug Administration Schedule | 1991 |
Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs.
Topics: Adolescent; Adult; Aged; Candidiasis; Candidiasis, Oral; Child; Double-Blind Method; Female; Flucona | 1991 |
Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Alanine Transaminase; Asparta | 1991 |
Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candidiasis, Oral; Clotrimazole; Fl | 1990 |
[Multicenter study of fluconazole in the treatment of oropharyngeal candidiasis in immunodepressed patients].
Topics: Adult; Candidiasis, Oral; Female; Fluconazole; HIV Infections; Humans; Immunologic Deficiency Syndro | 1990 |
Fluconazole treatment of fungal infections in the immunocompromised host.
Topics: Adolescent; Adult; Candidiasis, Oral; Child; Child, Preschool; Female; Fluconazole; Humans; Immune T | 1990 |
Prophylaxis of candidiasis in cancer patients.
Topics: Adolescent; Adult; Aged; Candidiasis, Oral; Double-Blind Method; Female; Fluconazole; Humans; Male; | 1990 |
Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Candidiasis, Oral; Clinical Trials | 1990 |
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidi | 1989 |
Fluconazole in the treatment of Candida-associated denture stomatitis.
Topics: Aged; Candidiasis, Oral; Clinical Trials as Topic; Double-Blind Method; Female; Fluconazole; Humans; | 1988 |
325 other studies available for fluconazole and Moniliasis, Oral
| Article | Year |
|---|---|
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Ora | 2007 |
Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis, Oral; DNA, Fungal; Drug Resistance, Fungal | 2010 |
Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp.
Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sen | 2021 |
The evaluation of the overexpression of the ERG-11, MDR-1, CDR-1, and CDR-2 genes in fluconazole-resistant Candida albicans isolated from Ahvazian cancer patients with oral candidiasis.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candid | 2022 |
Paeonol enhances treatment of fluconazole and amphotericin B against oropharyngeal candidiasis through HIF-1α related IL-17 signaling.
Topics: Acetophenones; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Fluc | 2022 |
Low level of antifungal resistance in Candida species recovered from Iranian HIV-associated oral infection.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; HIV Infections; | 2023 |
Identification and susceptibility testing of oral candidiasis in advanced cancer patients.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug | 2023 |
Molecular mechanisms of azole resistance in Candida glabrata isolated from oropharyngeal candidiasis in head and neck cancer patients.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole | 2023 |
Oral candidiasis in patients with kidney transplantation in Iran: prevalence and antifungal susceptibility pattern.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Fluconazole; Huma | 2023 |
Human Oropharyngeal Candidiasis: From Etiology to Current Treatment.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Fluconazole; Humans | 2023 |
Ethyl caffeate combined with fluconazole exhibits efficacy against azole-resistant oropharyngeal candidiasis via the EFGR/JNK/c-JUN signaling pathway.
Topics: Animals; Antifungal Agents; Azoles; Caffeic Acids; Candida albicans; Candidiasis, Oral; Drug Resista | 2023 |
Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Disk Diffusion Antimicrobial T | 2019 |
Development and characterization of a novel liquid crystalline system containing sodium alginate for incorporation of
Topics: Alginates; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Delivery Sys | 2020 |
Fluconazole-induced fixed drug eruption confirmed by extemporaneous patch testing.
Topics: Antifungal Agents; Candidiasis, Oral; Drug Eruptions; Female; Fluconazole; Hand Dermatoses; Humans; | 2020 |
Innovations for prevention and care of oral candidiasis in HIV-infected individuals: Are they available?-A workshop report.
Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; HIV Infections; Humans | 2020 |
Antimycotic Treatment of Oral Candidiasis in Warfarin Users.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antifungal Agents; Candidiasis, Oral; | 2021 |
Development and machine-learning optimization of mucoadhesive nanostructured lipid carriers loaded with fluconazole for treatment of oral candidiasis.
Topics: Animals; Candidiasis, Oral; Drug Carriers; Fluconazole; Lipids; Machine Learning; Nanoparticles; Nan | 2021 |
Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Fluconazole; Genetic Variation; HIV | 2021 |
Generalized Bullous Fixed Drug Eruption to Fluconazole with Positive Patch Testing and Confirmed Tolerance to Itraconazole.
Topics: Aged; Antifungal Agents; Candidiasis, Oral; Drug Eruptions; Drug Tolerance; Fluconazole; Humans; Itr | 2021 |
Lingua Villosa Nigra.
Topics: Administration, Topical; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidiasis, Oral; | 2017 |
In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Topics: Adult; Amphotericin B; Antifungal Agents; Burkina Faso; Candida albicans; Candidiasis; Candidiasis, | 2017 |
Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candida glabrata; Candida tropicalis; Candidia | 2018 |
VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antifungal Agents; Candida albicans; Candida glabrata | 2018 |
Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis, Oral; Female; F | 2018 |
ERG3 and ERG11 genes are critical for the pathogenesis of Candida albicans during the oral mucosal infection.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Fluconazole; Genes, Fungal; Mice; M | 2018 |
VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Funga | 2018 |
Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Cas | 2018 |
Diversity, frequency and antifungal resistance of Candida species in patients with type 2 diabetes mellitus.
Topics: Adult; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Diabetes M | 2018 |
Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility study.
Topics: Adult; Antifungal Agents; Brazil; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluco | 2018 |
[Factors related to oral candidiasis in HIV children and adolescents, species characterization and antifungal susceptibility].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candi | 2018 |
Severe candidal balanoposthitis on concurrent treatment with secukinumab and the antidiabetic agent empagliflozin (sodium-glucose cotransporter 2 inhibitor - SGLT2-inhibitor).
Topics: Administration, Oral; Angioedema; Antibodies, Monoclonal, Humanized; Antifungal Agents; Benzhydryl C | 2019 |
Candidiasis Causing Vocal Fold Leukoplakia: Review of Clinical and Pathological Results of 289 Cases With Vocal Fold Leukoplakia.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Aged; Antifungal Agents; Biopsy; Candidiasis, O | 2019 |
Azole susceptibility and resistance in Candida isolates from oral candidiasis and oral colonization in HIV positive patients.
Topics: Candida; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Itraconazo | 2011 |
Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida-associated denture stomatitis with or without diabetes.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis, Oral; Caspofungin; Diabetes Mellitu | 2013 |
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Lo | 2014 |
Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highl | 2014 |
Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Candidiasis, Oral; Fluconaz | 2014 |
Kinetics of oral colonization by Candida spp. during topical corticotherapy for oral lichen planus.
Topics: Administration, Topical; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candida albicans; | 2014 |
Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease.
Topics: Animals; Candida albicans; Candidiasis, Oral; Coinfection; Disease Models, Animal; Female; Fluconazo | 2015 |
The role of antifungal and antiviral agents in primary dental care.
Topics: Acyclovir; Amphotericin B; Antifungal Agents; Antiviral Agents; Candidiasis, Oral; Cheilitis; Dental | 2014 |
Comparison between bioluminescence imaging technique and CFU count for the study of oropharyngeal candidiasis in mice.
Topics: Animals; Candida albicans; Candidiasis, Oral; Colony-Forming Units Assay; Cortisone; Diagnostic Imag | 2015 |
Antifungal effect of Trachyspermum ammi against susceptible and fluconazole-resistant strains of Candida albicans.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Apiaceae; Candida albicans; Candidiasis, O | 2015 |
Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Chlorhexidine; Echinocan | 2016 |
Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan.
Topics: Administration, Topical; Adult; Aged; Amphotericin B; Antifungal Agents; Attitude of Health Personne | 2015 |
Oropharyngeal Candidiasis in Palliative Care Patients in Denmark.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis, Oral; Denmark; Drug Resista | 2015 |
Combination of Estrogen and Immunosuppressive Agents to Establish a Mouse Model of Candidiasis with Concurrent Oral and Vaginal Mucosal Infection.
Topics: Animals; Antifungal Agents; Candida; Candidiasis, Oral; Candidiasis, Vulvovaginal; Colony Count, Mic | 2016 |
In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.
Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Oral; Cytochrome P-450 Enzyme S | 2015 |
Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; ATP Binding Cassette Transporter, S | 2016 |
Candida glabrata Binding to Candida albicans Hyphae Enables Its Development in Oropharyngeal Candidiasis.
Topics: Animals; Candida albicans; Candida glabrata; Candidiasis, Oral; Cell Wall; Coinfection; Female; Fluc | 2016 |
Single-Dose Fluconazole Therapy for Oral Thrush in Hospice and Palliative Medicine Patients.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis, Oral; Female; Fluconazole; Hospice C | 2017 |
Etiologic Agents and Antifungal Susceptibility of Oral Candidosis from Romanian patients with HIV-infection or type 1 diabetes mellitus.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Diabetes Complications; Diabetes Mellitus, Type 1; Dr | 2016 |
Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Cattle; Chito | 2016 |
Esophageal tuberculosis with coexisting opportunistic infections in a renal allograft transplant recipient.
Topics: Antifungal Agents; Antitubercular Agents; Antiviral Agents; Candidiasis, Oral; Deglutition Disorders | 2017 |
Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 2008 |
Rapid desensitization to fluconazole (Diflucan).
Topics: Antifungal Agents; Asthma; Candidiasis, Oral; Desensitization, Immunologic; Drug Hypersensitivity; F | 2008 |
Candida fermentati from HIV patients in Chennai, South India.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Female; | 2008 |
Correlation between enzyme production, germ tube formation and susceptibility to fluconazole in Candida species isolated from patients with denture-related stomatitis and control individuals.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Case-Control Studies; Denture, Complete, Upper; Drug | 2008 |
Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspartic Acid Endopeptidases; Candida albicans; Candida tr | 2009 |
Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
Topics: Adolescent; Adult; Aged; Argentina; Candida; Candidiasis, Oral; Dental Plaque; DNA, Fungal; Drug Res | 2008 |
Design and in vitro/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: relationship between swelling, erosion, and drug release.
Topics: Adhesives; Antifungal Agents; Candidiasis, Oral; Cheek; Chromatography, High Pressure Liquid; Drug D | 2008 |
Severe cutaneous adverse drug reaction due to fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Biopsy; Candidiasis, Oral; Diagnosis, | 2008 |
In vitro activity of voriconazole against Mexican oral yeast isolates.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; HIV Infections; Humans; Mexico; M | 2010 |
Fluconazole mucoadhesive buccal films: in vitro/in vivo performance.
Topics: Acrylic Resins; Adhesiveness; Adult; Alginates; Antifungal Agents; Candidiasis, Oral; Carboxymethylc | 2009 |
[Unfortunately it is too often unrecognized. Burning pain in breast feeding].
Topics: Administration, Oral; Adult; Antifungal Agents; Breast Diseases; Breast Feeding; Candida; Candidiasi | 2009 |
Antifungal activity of miconazole against recent Candida strains.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Miconaz | 2010 |
[37-year old patient with fever, diarrhea and lymphadenopathy].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal | 2010 |
Fluconazole susceptibility and genotypic heterogeneity of oral Candida albicans colonies from the patients with cancer receiving chemotherapy in China.
Topics: Adult; Aged; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Oral; China; DNA, F | 2009 |
Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Chronic Disease; Drug Resistance, Fu | 2010 |
Disseminated cryptococcosis and fluconazole resistant oral candidiasis in a patient with acquired immunodeficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Body Fluids; Candida tropicalis; Candi | 2010 |
Microbiological screening of Irish patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy reveals persistence of Candida albicans strains, gradual reduction in susceptibility to azoles, and incidences of clinical signs of oral candid
Topics: Adolescent; Adult; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Child; Child, Pre | 2011 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Cand | 2011 |
Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis.
Topics: Animals; Antifungal Agents; Biofilms; Calcineurin; Candida; Candidemia; Candidiasis, Oral; Caspofung | 2011 |
Fungal endophthalmitis developing in asthmatic individuals treated with inhaled corticosteroids.
Topics: Administration, Inhalation; Aged; Amphotericin B; Anti-Asthmatic Agents; Asthma; Candidemia; Candidi | 2011 |
Preparation of fluconazole buccal tablet and influence of formulation expedients on its properties.
Topics: Acrylates; Acrylic Resins; Adhesiveness; Administration, Buccal; Animals; Candidiasis, Oral; Cellulo | 2011 |
Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Flucona | 2011 |
Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter.
Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazi | 2012 |
Oral candidosis: characterization of a sample of recurrent infections and study of resistance determinants.
Topics: Adult; Aged; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida alb | 2011 |
A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.
Topics: Animals; Candida albicans; Candidiasis, Oral; Disease Models, Animal; Drug Combinations; Drug Resist | 2012 |
Fluconazole mouthrinse and clotrimazole mouthpaint effective medications for patients with denture stomatitis (UT CAT #802).
Topics: Administration, Buccal; Antifungal Agents; Candidiasis, Oral; Clotrimazole; Fluconazole; Humans; Mou | 2011 |
Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Echinocandins; Female; F | 2012 |
Chlorhexidine is a highly effective topical broad-spectrum agent against Candida spp.
Topics: Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Fluconaz | 2013 |
Pseudomembranous candidiasis in HIV/AIDS patients in Cali, Colombia.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Oral | 2013 |
Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antifungal Agents; Antisickling Agents; Candida; Candida gla | 2013 |
Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Candida; Candida albicans; Candida glab | 2013 |
Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Or | 2002 |
Prognostic factors for the clinical effectiveness of fluconazole in the treatment of oral candidiasis in HIV-1-infected individuals.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Candidiasis, Oral; Female; Fluconazole; HIV Infe | 2002 |
Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Candida; Candidiasis, Oral; Drug Resistance, Fun | 2002 |
Thrush and breastfeeding.
Topics: Antifungal Agents; Breast Diseases; Candida albicans; Candidiasis; Candidiasis, Oral; Female; Flucon | 2002 |
[Ongoing treatment with omeprazole and appearance of oropharyngeal candidiasis].
Topics: Aged; Anti-Ulcer Agents; Antifungal Agents; Candida albicans; Candidiasis, Oral; Female; Fluconazole | 2002 |
Oral candidiasis, switching and antifungal resistance.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans | 2000 |
Proliferation of intracellular structure corresponding to reduced affinity of fluconazole for cytochrome P-450 in two low-susceptibility strains of Candida albicans isolated from a Japanese AIDS patient.
Topics: AIDS-Related Opportunistic Infections; Amino Acid Substitution; Antifungal Agents; Candida albicans; | 2003 |
A topical antifungal medication in immunocompromised patients.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Immunoc | 2003 |
Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candi | 2003 |
Oral candidosis in patients with removable dentures.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspartic Acid Endopeptidases; Candida; Candidiasis, Oral; F | 2003 |
A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Chlorpromazine; Dis | 2003 |
[The usage of micomax in the treatment of oral leptotrichiosis and candidosis].
Topics: Adult; Antifungal Agents; Bacterial Infections; Candidiasis, Oral; Drug Combinations; Female; Flucon | 2003 |
[Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidia | 2003 |
Generalized fungal infection in a patient with AIDS appearing as skin papules.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Cameroon; Candidiasis, Cutaneous; C | 2003 |
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.
Topics: Adult; Aged; Antifungal Agents; Candida glabrata; Candidiasis, Oral; Carcinoma, Squamous Cell; Chemo | 2004 |
Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients.
Topics: AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; CD4 Lymphocyte Count; DNA Fingerp | 2004 |
Patterns of antifungal prescribing in general dental practice.
Topics: Age Factors; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Prescriptions; Fluconazole; | 2004 |
[For oral candidiasis and co. Fluconazole remains in the forefront].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Can | 2004 |
Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Candidiasis, Oral; Cycl | 2004 |
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
Topics: Antifungal Agents; Candida glabrata; Candidiasis, Oral; Fluconazole; Head and Neck Neoplasms; Humans | 2004 |
A case of oral erosive candidosis in a kidney transplant patient.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Female; Fluconazole; Herpes Labialis; Humans | 2004 |
Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Humans; Microbial Sensit | 2005 |
Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida; Candidiasis, Oral; Drug Resis | 2005 |
Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Cohort Studies | 2005 |
DNA identification of the pathogen of candidal aspiration pneumonia induced in the course of oral cancer therapy.
Topics: Aerosols; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Base Se | 2005 |
Detection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Female; Fluconazole; HIV | 2005 |
Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Fungal; Femal | 2006 |
Laryngeal thrush.
Topics: Administration, Oral; Aged; Antifungal Agents; Candidiasis, Oral; Causality; Female; Fluconazole; Ho | 2005 |
In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
Topics: Antifungal Agents; Candida glabrata; Candidiasis, Oral; Caspofungin; Drug Resistance, Fungal; Drug S | 2005 |
Erythema multiforme induced by fluconazole.
Topics: Administration, Oral; Aged; Candidiasis, Oral; Dose-Response Relationship, Drug; Erythema Multiforme | 2005 |
Detection of Candida dubliniensis in Venezuela.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Or | 2005 |
Fluconazole prophylaxis in HIV disease, revisited.
Topics: Antifungal Agents; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans | 2005 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; | 2005 |
Oral epithelial cell antifungal activity: approaches to evaluate a broad range of clinical conditions.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral | 2005 |
Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Oral; DNA Fingerprinting; Drug Resistance, | 2006 |
Fluconazole-resistant pseudomembranous oral candidiasis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Fungal; Female; Flucon | 2006 |
[Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazol | 2006 |
[Antifugal susceptibility testing and antifugal traditional Chinese medicines screening of oral Candida isolated from head and neck cancer patients treated with radiotherapy or chemotherapy].
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Fluconazole; Head and Neck Neoplasm | 2006 |
Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis.
Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; Hexetidine; Humans; Oral Hygiene; Stomatitis, Den | 2006 |
Oral candidiasis infections with limited clinical findings.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Chronic Disease; Female; Fluconazole; Humans; Male; Mid | 2006 |
The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral | 1999 |
Oral and maxillofacial pathology case of the month. Oral candidiasis associated with inhaled corticosteroid use.
Topics: Androstadienes; Antifungal Agents; Bronchodilator Agents; Candidiasis, Oral; Female; Fluconazole; Fl | 2006 |
Development of a new real-time TaqMan PCR assay for quantitative analyses of Candida albicans resistance genes expression.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candid | 2007 |
Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Case-Control Studies; Cell Adhesion; Denture | 2006 |
Evaluation of adhesion to buccal epithelial cells in Candida species obtained from denture wearers after exposure to fluconazole.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Cell Adhesion; Dentures; Epithelial Cells; Fluconazol | 2007 |
A novel murine model of pharyngeal candidiasis with local symptoms characteristic of pharyngeal thrush produced by using an inhaled corticosteroid.
Topics: Administration, Inhalation; Animals; Antifungal Agents; Beclomethasone; Candida albicans; Candidiasi | 2007 |
[Oral isolates of Saccharomyces in patients with oral fungal infection and their susceptibility to antifungal drugs].
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Fluconazole; Humans; Ketoconazole; Nystatin; | 2007 |
Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Area Under Curve; Candida; Candidiasi | 2007 |
Oral manifestation of chronic mucocutaneous candidiasis: seven case reports.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; C | 2007 |
In vitro inhibition of oral Candida albicans by chicken egg yolk antibody (IgY).
Topics: Animals; Antibodies, Fungal; Antibody Specificity; Candida albicans; Candidiasis, Oral; Chickens; Dr | 2008 |
Fluconazole-resistant oral candidosis in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance; Flucon | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Fulminant cryptococcal infections in HIV-infected patients on oral fluconazole.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis, Oral; Cryptococcosi | 1995 |
Comparison of different treatment methods for localized and generalized simple denture stomatitis.
Topics: Administration, Oral; Candida albicans; Candidiasis, Oral; Chlorhexidine; Colony Count, Microbial; D | 1995 |
Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida; Candidiasis; Candidiasis, Oral; Dermatomycose | 1995 |
DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; DNA, Fungal; Fema | 1995 |
Use of a colorimetric system for yeast susceptibility testing.
Topics: AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; Colorimetry; Coloring Ag | 1995 |
Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Candidiasis, Vulvovaginal; | 1994 |
Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Candida albicans; Candidiasis, Oral; D | 1994 |
[Fungemia caused by Candida krusei in a female patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida; Candidiasis, Oral; Female; Fluco | 1994 |
Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Cohor | 1994 |
Relationship between fluconazole sensitivity of Candida albicans isolates from HIV positive patients and serotype, adherence and CD4+ lymphocyte count.
Topics: AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; CD4 Lymphocyte Count; Co | 1994 |
Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Candidiasis, Oral; | 1994 |
[Fluconazole sensitivity of Candida strains in vitro in the microdilution test and agar diffusion test].
Topics: AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Fluconazole; Humans; Immunodiffus | 1994 |
Fluconazole prophylaxis in AIDS: the jury is not yet out.
Topics: AIDS-Related Opportunistic Infections; Candidiasis, Oral; Contraindications; Drug Resistance, Microb | 1995 |
Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Candida albicans; Candidiasis, Oral; DNA, Fungal; Drug Resistanc | 1994 |
Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Cross-Sectiona | 1994 |
[Progressive resistance to fluconazole in a patient with HIV infection and recurrent oropharyngeal candidiasis].
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Drug Resistance, Micro | 1994 |
Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.
Topics: AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbi | 1994 |
Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Candida albicans; Candidiasis; Candidiasis, O | 1994 |
Fluconazole-insensitive OPC in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Fluco | 1994 |
Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans.
Topics: Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Evaluation Studies as Topic; Flucon | 1994 |
Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; DNA, Fungal; Drug | 1994 |
Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Fluconazole; Humans; Male | 1993 |
Therapy for oropharyngeal candidiasis in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Candidiasis, Oral; Clotrimazole; Fluconazole; HIV Infections; | 1993 |
[Resistance of Candida sp. to fluconazole in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Fluconaz | 1993 |
Fluconazole-induced toxic epidermal necrolysis in a patient with human immunodeficiency virus infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis, Oral; Fluconazole; HIV Infections; Humans | 1993 |
Fluconazole-resistant Candida in AIDS patients. Report of two cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; Drug Resistance, | 1993 |
Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.
Topics: Adult; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; HIV Ser | 1993 |
Pemphigus vulgaris precipitated by glibenclamide therapy.
Topics: Aged; Azathioprine; Candidiasis, Oral; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Fluconazole | 1993 |
Fluconazole chemoprophylaxis in neutropenic patients.
Topics: Adult; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Leukemia, Myeloid | 1993 |
[Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Drug Resistance, Micro | 1993 |
Fluconazole-resistant Candida albicans after long-term suppressive therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis; Candidiasis, Oral; Drug | 1993 |
The prophylactic use of fluconazole 50 vs. 100 mg daily in haematological malignancies.
Topics: Adolescent; Adult; Aged; Candidiasis, Oral; Female; Fluconazole; Humans; Leukemia, Myeloid; Lymphoma | 1993 |
Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; DNA, Fungal; Drug | 1995 |
Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Case-Co | 1996 |
Weekly fluconazole for the suppression of recurrent thrush in HIV-seropositive patients: impact on the incidence of disseminated cryptococcal infection.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Cryptococcosis; Female; Fluconazole; HIV Infections; Hu | 1995 |
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alleles; Antifungal Agents; Candida albicans; Candidiasis | 1995 |
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; ATP Binding Cassette Transporter, Subfamil | 1995 |
Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Color | 1995 |
Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1996 |
Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconaz | 1996 |
Prophylaxis of candidiasis in patients with leukemia and bone marrow transplants.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bone Marrow Transplantation; Candidiasis, Oral; Dental C | 1996 |
Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis | 1995 |
Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 1996 |
Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; | 1996 |
Candida albicans osteomyelitis of the zygomatic bone. A distinctive case with a possible peculiar mechanism of infection and therapeutic failure with fluconazole.
Topics: Administration, Inhalation; Amphotericin B; Biopsy; Candidiasis; Candidiasis, Oral; Diabetes Complic | 1996 |
Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Carri | 1996 |
Genetic dissimilarity of two fluconazole-resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Base Sequence; Candida albicans; Ca | 1996 |
[Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral | 1996 |
[Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Ca | 1996 |
[A new pharmaceutical concept for the therapy of oropharyngeal and esophageal candidiasis with fluconazole].
Topics: Administration, Oral; Aged; Antifungal Agents; Candidiasis; Candidiasis, Oral; Cross-Over Studies; E | 1996 |
Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.
Topics: Agar; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Chromogenic Compounds; Cultur | 1996 |
Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Female; Fluconazole; Human | 1996 |
Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug | 1996 |
Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidia | 1996 |
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; C | 1996 |
Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.
Topics: Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis, Oral; Case-Control Studies; Drug Admi | 1996 |
Relationship between fluconazole dosage regimens and the emergence of fluconazole-resistant Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; HIV | 1996 |
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococ | 1996 |
Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug | 1996 |
Rationalizing prescribing for oral and oesophageal candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Costs | 1996 |
Cheilo-candidosis in an adult.
Topics: Adult; Candidiasis, Oral; Female; Fluconazole; Humans; Lip; Lip Diseases; Sjogren's Syndrome; Sunlig | 1996 |
Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida; Candidiasis, Oral; CD4 Lymphocyte Co | 1997 |
Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole-susceptible oral candidosis.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; CD4 Lymphocyte Count; Drug Resistance, Microbial; Flu | 1997 |
Fluconazole suspension for oropharyngeal candidiasis unresponsive to tablets.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, | 1997 |
In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; HIV | 1997 |
Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Mic | 1997 |
Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral | 1997 |
Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; CD4 Lymphocyte Count; Flucon | 1997 |
[Oral amphotericin B inefficacy in the treatment of fluconazole++ resistant oropharyngeal candidiasis in HIV-positive patients].
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole | 1996 |
Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; DNA, | 1997 |
Effects of systemic fluconazole therapy on in vitro adhesion of Candida albicans to buccal epithelial cells and changes of the cell surface proteins of the epithelial cells.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Oral; Epithelium; Female; Fluconazole; Huma | 1996 |
Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; DNA, | 1997 |
Exfoliative cheilitis (EC) in AIDS: association with Candida infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidia | 1997 |
Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antifungal Agents; Candida albicans; Candidias | 1997 |
Treating oral candidiasis: potentially fatal.
Topics: Anti-Bacterial Agents; Anticoagulants; Antifungal Agents; Candidiasis, Oral; Drug Interactions; Eryt | 1997 |
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidias | 1997 |
Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
Topics: 17-Hydroxycorticosteroids; Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections | 1997 |
Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Oral; Carrier State; CD4 Lymphocyte Count; Drug Resi | 1997 |
Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Bone Marrow Transplantation; Candida albicans; Can | 1997 |
Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 1997 |
Widespread cutaneous cryptococcosis occurring in an immunocompromised patient treated with high doses of fluconazole for oro-pharyngeal candidosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Cryptococcosis; | 1997 |
Weekly fluconazole for preventing mucosal candidiasis in HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Candidiasis, Vulvovagin | 1997 |
Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug | 1997 |
[Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Or | 1997 |
Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Ora | 1997 |
Fluconazole resistant oral candidiasis in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Case-Control S | 1997 |
Neutrophil phagocytosis in AIDS patients with azole resistant candidiasis.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles | 1997 |
Fluconazole susceptibility of Candida isolates from oropharyngeal candidosis.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Humans; Microbial Sensitivity Tests; Tre | 1997 |
Reduction in oropharyngeal candidiasis following introduction of protease inhibitors.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Candidiasis, Oral; | 1998 |
Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Candidiasis, Oral; Drug R | 1998 |
[Candida humicola infection of the central nervous system in an HIV-infected patient: a case report].
Topics: Adult; Antifungal Agents; Brain; Candidiasis, Oral; Fatal Outcome; Fluconazole; HIV Seropositivity; | 1997 |
Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Female; Fluconazole; Humans; Male; Microbial Sensitivit | 1998 |
Prior fluconazole exposure as an independent risk factor for fluconazole resistant candidosis in HIV positive patients: a case-control study.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Case-Control Studies; C | 1997 |
Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients.
Topics: Adult; Agar; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; CD4 Lymphocyte Count; | 1998 |
Transmission of fluconazole-resistant Candida strains between HIV-positive patients and their sexual partners.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; HIV | 1998 |
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albi | 1998 |
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral | 1998 |
Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candid | 1998 |
Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Candida albicans; Candidi | 1998 |
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasi | 1998 |
Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Candidiasis, Oral; | 1998 |
Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
Topics: Adhesiveness; Administration, Topical; Amphotericin B; Analysis of Variance; Antifungal Agents; Cand | 1998 |
Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antifungal Agents; Azoles; Brazil; Candida albicans | 1998 |
Identification of Candida dubliniensis in a prospective study of patients in the United States.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Culture | 1999 |
Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Ora | 1998 |
A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Evaluation Stu | 1999 |
Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candidiasis; Candidiasis, | 1999 |
In vitro activity of rilopirox against fluconazole-susceptible and fluconazole-resistant Candida isolates from patients with HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 1999 |
Efficacy, safety and toleration of fluconazole suppositories in the treatment of oral candidosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis, Oral; Capsules; Female; | 1999 |
Low levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antibodies, Fungal; Antifungal Agents; Antigenic Variation; A | 1999 |
Myeloperoxidase deficiency associated with atypical oral candidiasis: A clinical report.
Topics: Antifungal Agents; Candidiasis, Oral; Denture Rebasing; Denture, Complete, Upper; Female; Fluconazol | 1999 |
Molecular aspects of fluconazole resistance development in Candida albicans.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug | 1999 |
Further characterization of human salivary anticandidal activities in a human immunodeficiency virus-positive cohort by use of microassays.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral | 1999 |
Successful treatment of fluconazole-resistant oropharyngeal candidiasis by a combination of fluconazole and terbinafine.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Drug Therapy, Combination; | 1999 |
Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; DMF Index; DNA, Fungal; Female; Fluconazole; HIV Sero | 1999 |
Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Culture Media; Fluconazole; Head and Neck Neoplasms; | 1999 |
Effect of fluconazole on the growth and adhesion of Candida albicans in the presence of antineoplastic agents.
Topics: Antifungal Agents; Antineoplastic Agents; Candida albicans; Candidiasis, Oral; Cell Adhesion; Drug I | 1999 |
Evolution of drug resistance in experimental populations of Candida albicans.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Colon | 2000 |
Clonal and spontaneous origins of fluconazole resistance in Candida albicans.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis | 2000 |
Evaluation of phenotypic markers for selection and identification of Candida dubliniensis.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Base Sequence; beta-Glucosida | 2000 |
Diabetes insipidus in a patient with a highly malignant B-cell lymphoma and stomatitis.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasis, Oral; Cycloph | 2000 |
Efficacy of antifungal agents in tissue conditioners in treating candidiasis.
Topics: Acrylic Resins; Aged; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; | 1999 |
Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Topics: Animals; Candidiasis; Candidiasis, Oral; Child; Colony Count, Microbial; Disease Models, Animal; Dru | 2000 |
Therapeutic experience with fluconazole in the treatment of fungal infections in diabetic patients.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Oral; Candidiasis, Vulvovaginal; Diabetes Complic | 1999 |
Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-gamma.
Topics: Animals; Candida albicans; Candidiasis; Candidiasis, Oral; Disease Models, Animal; Drug Therapy, Com | 2000 |
Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; | 2000 |
[Multiple medullary and extramedullary plasmacytomas in an HIV infected female patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Brain Neoplasms; Candidiasis, Oral; | 2000 |
Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Carrier | 2000 |
Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Female; Fluconazole; Humans; Itraconazo | 2000 |
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Resi | 2001 |
The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidia | 2001 |
Fluconazole prevents yeast infections in women with HIV.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Candidiasis, Vulvovagin | 1996 |
No resistance to fluconazole with short-term treatment for oral thursh.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Immuno | 1996 |
Fungal infection overview.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Candidiasis | 1995 |
Candidiasis at ICAAC.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Biological Availabil | 1995 |
Candidiasis clinical study.
Topics: Antifungal Agents; Candidiasis, Oral; CD4 Lymphocyte Count; Clinical Trials as Topic; Fluconazole; H | 1998 |
Antifungal resistance of candidal biofilms formed on denture acrylic in vitro.
Topics: Acrylic Resins; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Biofilms; Candida a | 2001 |
Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
Topics: Adult; Antifungal Agents; Candida; Candida albicans; Candidiasis; Candidiasis, Oral; Carcinoma, Squa | 2001 |
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agent | 2001 |
Can fluconazole concentrations in saliva be used for therapeutic drug monitoring?
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Monit | 2001 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; | 2001 |
Salivary anticandidal activity and saliva composition in an HIV-infected cohort.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Oral; Case-Control Studies; Cohort Studies; | 2001 |
Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.
Topics: Adult; AIDS-Related Opportunistic Infections; Ambulatory Care; Antifungal Agents; Candida albicans; | 2001 |
Thrush in the breastfeeding dyad: results of a survey on diagnosis and treatment.
Topics: Adult; Antifungal Agents; Breast Diseases; Breast Feeding; Candidiasis; Candidiasis, Oral; Female; F | 2001 |
Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Female; | 2001 |
Fluconazole susceptibility of Italian Candida dubliniensis clinical isolates determined by reference and simplified tests.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Colorimetry; Drug Resistance, Fungal; Fluconazole; Hu | 2001 |
Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis, Oral; Capsules; | 2002 |
Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug | 2002 |
Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatients.
Topics: Adult; Antifungal Agents; Blotting, Southern; Candida albicans; Candidiasis, Oral; Carrier State; Ch | 2002 |
Identification of Candida dubliniensis among oral yeast isolates from an Italian population of human immunodeficiency virus-infected (HIV+) subjects.
Topics: Adult; Agar; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Chromogenic Compounds; | 2002 |
Multicenter Brazilian study of oral Candida species isolated from AIDS patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidia | 2002 |
Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Topics: Amino Acid Sequence; Antifungal Agents; ATP-Binding Cassette Transporters; Blotting, Northern; Candi | 2002 |
Fluconazole for postpartum candidal mastitis and infant thrush.
Topics: Adult; Antifungal Agents; Candidiasis; Candidiasis, Oral; Female; Fluconazole; Humans; Infant, Newbo | 2002 |
In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Azoles; Candida alb | 2002 |
Adherence of different Candida dubliniensis isolates in the presence of fluconazole.
Topics: AIDS-Related Opportunistic Infections; Candida; Candida albicans; Candidiasis, Oral; Cell Adhesion; | 2002 |
Effect of commercial ethanol propolis extract on the in vitro growth of Candida albicans collected from HIV-seropositive and HIV-seronegative Brazilian patients with oral candidiasis.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Brazil; Candida alb | 2002 |
Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Esophageal Disea | 1992 |
Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation.
Topics: Candida albicans; Candidiasis, Oral; DNA, Fungal; Fluconazole; HIV Infections; Humans; Ketoconazole; | 1992 |
Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases.
Topics: Biopsy; Candidiasis; Candidiasis, Oral; CD4-CD8 Ratio; Drug Administration Schedule; Esophagitis; Es | 1992 |
Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model.
Topics: AIDS-Related Opportunistic Infections; Animals; Candida albicans; Candidiasis; Candidiasis, Oral; Cr | 1992 |
[Treatment and secondary prophylaxis with fluconazole for oropharyngeal candidiasis in HIV-positive patients. A mycological analysis of failures].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Candida albicans; Candidiasis, Oral; Female; | 1992 |
Cavitating pulmonary cryptococcosis developing in an HIV antibody patient despite prior treatment with fluconazole.
Topics: Adult; Candidiasis, Oral; Cryptococcosis; Fluconazole; HIV Seropositivity; Humans; Lung Diseases, Fu | 1992 |
Dose-dependent fluconazole hepatotoxicity proven on biopsy and rechallenge.
Topics: Candidiasis, Oral; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug In | 1992 |
Stevens-Johnson syndrome after fluconazole.
Topics: Adult; Candidiasis, Oral; Fluconazole; HIV Seropositivity; Homosexuality; Humans; Male; Stevens-John | 1991 |
Yeasts susceptibility testing.
Topics: Acquired Immunodeficiency Syndrome; Candida albicans; Candidiasis, Oral; Fluconazole; Humans; Microb | 1991 |
Fluconazole resistant candida in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazol | 1991 |
Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Candidiasis, Oral; Drug Evaluation; Esophagitis; | 1991 |
Fluconazole resistance in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fl | 1991 |
Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole.
Topics: Amphotericin B; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans | 1991 |
Treatment of refractory oral candidiasis with fluconazole. A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida albicans; Candidiasis, Oral; Clot | 1991 |
Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Fluconazole; Humans; Liver; Male | 1991 |
Fluconazole resistant candida in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazol | 1991 |
Candida albicans resistance in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal | 1991 |
[Antimycotic agents selectively damages the fungus membrane. AIDS patients--cryptococcosis--oropharyngeal candidiasis].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans | 1991 |
Maintenance therapy of oropharyngeal candidiasis in HIV-infected patients with fluconazole.
Topics: Administration, Oral; Adult; Candidiasis, Oral; Female; Fluconazole; HIV Infections; Humans; Male | 1990 |
AIDS file. New oral antifungal may replace i.v. treatment.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Candidiasis, Oral; Fluconazole; Humans; Op | 1990 |
High dose oral fluconazole for oropharyngeal candidosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Candidiasis, Oral; Fluconazole; Humans; Ma | 1990 |
Fluconazole in the treatment of refractory oral candidiasis and tinea pedis in an elderly patient.
Topics: Aged; Candidiasis, Oral; Female; Fluconazole; Humans; Tinea Pedis | 1990 |
Fluconazole for ketoconazole-resistant oropharyngeal candidiasis in HIV-1 infected patients.
Topics: Adult; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; HIV Infections; HIV-1; Hu | 1990 |
Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Pilot | 1989 |
[AIDS: bad prognosis in candidiasis. Cryptococcosis in brain involvement is usually fatal--experiences with a new therapeutic drug].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningit | 1989 |
[Clinical evaluation of fluconazole in patients with mycotic infection].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis; Candidia | 1989 |
Treatment of candidal leukoplakia with fluconazole.
Topics: Antifungal Agents; Candidiasis, Oral; Cheilitis; Fluconazole; Humans; Male; Middle Aged; Triazoles | 1989 |
A comparison of fluconazole and ketoconazole in the treatment of rat palatal candidosis.
Topics: Animals; Antifungal Agents; Candidiasis, Oral; Epithelium; Fluconazole; Image Processing, Computer-A | 1989 |
Fluconazole found effective against candidiasis.
Topics: Candidiasis; Candidiasis, Oral; Fluconazole; Humans; Oropharynx; Pharyngeal Diseases | 1989 |
Jaundice in HIV positive haemophiliac.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Fluconazole; Hemophilia A; HIV Seropositivity; Humans; | 1989 |
Fluconazole versus ketoconazole in oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Female; Fluconazole; Humans; Ketoconazole; Ma | 1989 |
Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients.
Topics: Adult; Aged; Candida albicans; Candidiasis; Candidiasis, Oral; Female; Fluconazole; HIV Seropositivi | 1988 |
Fluconazole for the treatment of fungal diseases in immunosuppressed patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Candidiasis, Oral; Cryptococcosis; Flu | 1988 |